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INTRODUCTION 
  
Endophthalmitis is a potentially devastating complication of 
cataract surgery that every ophthalmic surgeon and patient strives to 
avoid. It can lead to anatomical and functional loss of affected eye. 
 There are several studies on the epidemiology and incidence of 
endophthalmitis in both Western and Indian literature. A lot of advances 
have been achieved in the field of microbiological diagnosis and 
antibiotic prophylaxis for endophthalmitis. Rapid diagnosis is made 
possible by techniques like PCR from samples collected from intra ocular 
fluids. 
The identification of prognostic factors at the time of modern clear 
corneal cataract surgery is a main step in identifying patients who need 
early aggressive treatment .It has been reported in EVS study that initial 
vision, absence of red reflex ,history of diabetes and glaucoma and 
bacterial species involved are associated with prognosis of 
endophthalmitis.  
Recent changes in cataract surgery techniques and different 
epidemiological features in different places, demand new data to study 
the factors which would have led to good or poor prognosis in these 
patients. The purpose of this study is to reveal pre operative, intra 
 
 
operative and post operative risk factors which may affect the outcome in 
patients with acute endophthalmitis and to necessitate the need for 
aggressive treatment. 
  
 
 
REVIEW OF LITERATURE 
DEFINITION AND CLASSIFICATION 
Endophthalmitis is a potentially severe inflammation of intraocular 
tissues and fluids. Although non-infectious processes may also cause 
endophthalmitis, infectious type are potentially catastrophic.    
Infectious endophthalmitis can be exogenous, endogenous or post 
traumatic. 
 Exogenous endophthalmitis is due to breach in external ocular 
barriers which allows entry of infectious organism into intraocular 
spaces, most commonly following cataract surgery. It can be 
fulminant, acute onset, or delayed onset endophthalmitis, bleb 
associated endophthalmitis and sterile endophthalmitis. Another 
classification of exogenous endophthalmitis is early onset and 
delayed onset. 
 Fulminant endophthalmitis comes under early onset 
endophthalmitis and manifests within 4 days of intraocular surgery 
due to high virulent pathogens. 
 Acute onset type manifests within 6 weeks of surgery. Most 
commonly caused by coagulase negative staphylococcus like 
Staphylococcus epidermidis. Others include gram negative rods 
 
 
including Proteus and Serratia, Staphylococcus aureus and 
Streptococcus species. 
 Delayed onset endophthalmitis manifests more than 6 weeks 
following surgery. It is caused by organisms of low virulence like 
Propionibacterium acnes, Staphylococcus epidermidis and fungi. 
 Bleb related endophthalmitis following glaucoma filtering 
procedure may occur during early or late postoperative period. 
Most common causative organisms include Streptococcus spp. and 
Hemophilus influenzae. 
 Endogenous endophthalmitis is less common and the organisms 
reach via bloodstream and by crossing blood ocular barrier. 
 Post traumatic infectious endophthalmitis  occurs commonly 
following penetrating trauma and intraocular foreign body. 
Incidence of acute onset endophthalmitis following cataract 
extraction was found to be 0.072% to 0.13% [2] 
Risk factors include type of cataract extraction, intraoperative 
complications like posterior capsule rupture with vitreous loss. [3] 
The classical presentation of acute endophthalmitis is history of pain and 
redness in the operated eye and diminision of vision. Signs include lid 
edema, hypopyon, Anterior chamber cells and flare, fibrinous reaction in 
pupillary region, vitreous reaction etc. 
 
 
It has been reported that post operative inflammation more than 
expected should always arise the suspicion of endophthalmitis. [4] Lab 
Diagnosis of endophthalmitis is done by collecting anterior chamber 
fluid, vitreous cavity 
Contents, iris tissue, explanted IOLs and eviscerated contents and 
enucleated globe.[4] Microbiological evaluation by smears and culture are 
carried out subsequently. 
Medical management includes topical fortified antibiotics, 
cycloplegics and corticosteroids every hourly or two hourly. 
The principle modality of treating an infectious endophthalmitis is 
administration of intravitreal antibiotics. Current recommendation being 
combined therapy of intravitreal vancomycin and ceftazidime providing a 
broad spectrum coverage[4] 
Despite aggressive medical treatment, if there are no signs of 
improvement clinically after 48 hours, or suspected fungal infection or 
advanced initial presentation, core vitrectomy is the surgical procedure of 
choice.  
 
 
 
 
 
 
EPIDEMIOLOGY 
Epidemiology seems to be changing over years. The incidence of 
post operative endophthalmitis in the present era has decreased 
significantly from 1% to 0.05-0.01% inspite of improved asepsis and 
sterilisation techniques. 
Bacteria are the most common group of organisms causing 
endophthalmitis. Of these, gram positive bacteria are more common. 
Staphylococcus epidermidis is the most common isolate followed by 
Staphylococcus aureus. Others include Streptococcus pneumonia, 
Streptococci and Corynebacterium. 
Bacillus spp. are very rare and are known to cause acute infection 
with poor visual prognosis. 
The spectrum of infective organisms is shifting to gram negative 
species and fungi. In India, a higher prevalence of gram negative 
organisms and fungi have been reported by Kunimoto et al. [5] 
Anand et al has reported isolation of 41.7% of gram negative species and 
37.6% of gram positive bacteria and 21.8% of fungi.[6] 
Gram negative organisms causing post operative endophthalmitis 
include Pseudomonas aeroginosa, which is the most commonest, 
followed by Proteus mirabilis, Klebsiella pneumonia, Hemophilus 
influenza, E.Coli and Enterococci. 
 
 
A study from South India revealed Nocardia Spp. as the 
predominant isolate from patients with post cataract endophthalmitis [4] 
Endophthalmitis due to fungal infection is rare and is caused by both 
saprophytes and opportunistic fungi like Candida, Fusarium and 
Aspergillus. 
MICROBIOLOGY AND PATHOLOGY 
The organisms responsible for endophthalmitis may vary in 
different regions of the world, the predominant being Gram positive 
bacteria as reported in EVS study. [7] 
Gram positive organisms 
Staphylococcus species 
Staphylococcus epidermidis is the most common organism causing 
post operative endophtalmitis. It is a coagulase negative staphylococci. [8] 
Staphylococcus aureus are second most common cause. They are 
coagulase positive facultative anaerobes. They are highly virulent, 
causing endophthalmitis within a week of surgery and the visual outcome 
is less favourable. [9] 
Other staphylococci like S.epidermidis, S.hominis, S.capitis etc. 
also have similar clinical presentation with better prognosis. 
 
 
 
 
Streptococcus species 
These are gram positive, catalase negative organisms. 
Streptococcus pneumoniae is a normal commensal in the 
nasopharynx. Any obstruction to the nasolacrimal outflow will predispose 
their colonization of conjunctiva. [10]Other common organisms include 
Streptococcus viridians and Streptococcus pyogenes. 
Bacillus species are gram-positive aerobic, spore forming bacteria. 
They cause acute infection and associated with poor visual prognosis. 
But, post operative bacillus endophthalmitis have a better visual outcome 
than traumatic bacillus endophthalmitis, which is much commoner. [11] 
Propionibacterium acnes is a gram-positive, aerobic bacillus causing 
chronic postoperative bacterial endophthalmitis. Their resistant bacterial 
cell wall increases its viability for a longer duration. This has been 
reported after Extracapsular cataract extraction.[12] 
Actinomycetes are gram-positive organisms which develop 
filaments resembling fungal hyphae.  Actinomyces isreli and Nocardia 
asteroides are important members of this group. 
 
 
 
 
 
 
Gram negative organisms 
They are virulent organisms known to cause fulminant 
endophthalmitis and poor visual outcome. 
Pseudomonas aeruginosa is extremely notorious to cause extensive 
infection and damage to the eye. Other gram-negative bacteria like 
Hemophilus, Protcus, and Klebsiella species, Serratia marcescens etc. 
have also been isolated. 
 Enterobacteriaceae family of gram negative rods also are 
associated with a poor visual prognosis. 
Fungus 
Although fungal infections are rare in Western countries, it has 
been reported to have a higher incidence in the recent years in India. 
A study in North India showed culture positive endophthalmitis with 
predominant fungal organisms followed by gram negative and very less 
gram positive organisms. [13] 
Post cataract endophthalmitis is caused mainly by moulds like 
aspergillus which is the commonest, followed by Fusarium. [14]Other 
fungal organisms isolated include Cephalosporium, Penicillium, and 
Peniciliomyces. 
 
 
 
 
Pathology 
Acute endophthalmitis is characterized by a recruitment of 
neutrophils which actively produce reactive oxygen species as a host 
defence mechanism. This causes much damage to the eye and visual loss. 
Repair of damaged tissues results in scar formation by fibrosis and 
gliosis. 
 The inflammatory process may be of two types- suppurative, 
characterized by  pus production, and  non suppurative. Staphylococcal 
species are pyogenic organisms producing purulent inflammation. 
 
Chronic inflammation is characterized by the influx of 
lymphocytes.It is further classified  into granulomatous and 
nongranulomatous types. Granulomatous inflammation is characterized 
by the presence of epithelioid cells and giant cells and is usually found in 
fungal infection. 
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Irreversible damage to photoreceptor 
cells and collateral damage to the eye. 
 
 
 
Bacterial virulence play an important role in the pathogenesis and 
outcome of infectious endophthalmitis. 
 S. aureus is a virulent intraocular pathogen. S. aureus endophthalmitis 
has been reported to result in final visual acuities of 20/400 or worse 
in more than half of the reported cases. [15] Globally regulated toxins, 
like alpha-toxin, are key virulence factors in  S.aureus  
endophthalmitis. 
 Enterococcus faecalis is a gram-positive, facultative anaerobe 
commonly associated with antibiotic-resistant nosocomial infections. 
They produce exotoxins called cytolysins which caused severe retinal 
damage in mammalian cells. 
 Streptocccus pneumonia also produce exotoxins like pneumolysin and 
autolysins which are responsible for its virulence. 
 Coagulase-negative staphylococci like S. epidermidis produce biofilm 
which occurs as the organisms replicate collectively on the surface of 
a biomaterial, where they become embedded in a multilayered mass of 
bacteria and extracellular polysaccharide. They show increased 
adherence to polypropylene lenses than to PMMA and Acrysof     
IOLs. [16] 
 
 
 Bacillus cereus replicate and migrate rampantly throughout all parts of 
the eye, producing an intense intraocular inflammatory response in 
parallel with deteriorating retinal architecture. 
 P. acnes produce proteases and fibronectin-binding protein that may 
aid in its adhesion to IOLs and contribute to virulence during 
infection. The inherent slow replication rate of the organism is thought 
to contribute to the indolent nature of the disease. 
 Gram negative organisms like Pseudomonas aeruginosa, are avid 
biofilm producers, which may be a source of infection via adherence 
to IOLs. 
 Exogenous fungal endophthalmitis are relatively rare. It has been 
proposed that the rates of fungal endophthalmitis are determined by 
climate rather than the mechanism of injury, such that warmer, more 
tropical areas have a higher incidence of fungal organisms. [17] 
 Culture negative cases are due to low level of inoculums undetected 
by conventional culture and PCR techniques despite infection. [18] 
 
 
 
 
 
 
 
CLASSIFICATION 
Infectious endophthalmitis [19] 
 Post operative endophthalmitis 
 Acute onset endophthalmitis 
 Delayed onset endophthalmitis  (presentation >6weeks 
postoperatively) 
 Conjunctival filtering bleb associated 
 Endogenous endophthalmitis 
 Post traumatic endophthalmitis 
 
Non Infectious endophthlmitis [20] 
 Sterile uveitis 
 Phaco anaphylactic endophthalmitis 
 Sympathetic Ophthalmia 
 
RISK FACTORS 
Post operative endophthalmitis may be secondary to: 
1. Introduction of an overwhelming inoculum or               
2. Inadequate Immune response of the host. 
 
 
 
Risk factors for post cataract endophthalmitis can be further classified 
into: 
 Pre operative 
 Intra operative 
 Post operative 
Pre operative Risk factors [20] 
 Blepharitis 
 Canaliculitis 
  Dacryocystitis 
  Bacterial or viral conjunctivitis 
 H/o contact lens wear 
 Other eye ocular prosthesis  
 Immune suppression of  host 
 Diabetes mellitus  
 Urt infections 
 Old age (>90yrs) 
 Atopic dermatitis  
 Keratoconjunctivitis  sicca 
 
 
 
 It has been reported that patients with diabetes mellitus were more 
likely to get gram negative endophthalmitis and a poorer visual prognosis 
following treatment than other treated patients. [21] 
Lacrimal or eyelid procedures dramatically increased the risk of 
endophthalmitis. [22] 
 
Intra operative risk factors (20) 
 Inadequeate eyelid/conjunctival disinfection 
  inapparent or unplanned ocular penetration during peribulbar or 
retrobulbar anaesthesia 
 Inadequate draping and cleaning of the lids and lashes away from 
Surgical site.[23] 
 Prolonged surgery(longer than 60 minutes) 
 Vitreous loss due to PC rent or zonular dialysis 
 Use of  IOL haptics  made of prolene and silicone  
 Presence of lens matter 
Jager et al has reported that vitreous loss during cataract surgery is 
significantly associated with endophthalmitis. [24] 
 
 
 
 
 
Post operative risk factors [20] 
 Wound leak/dehiscence 
 Inadequately buried sutures 
 Suture removal, 
 Vitreous incarceration in the surgical wound 
 Post operative hypotony 
 
Sclera tunnels, which lie in relatively avascular sclera, create a 
potential abscess cavity when inoculated by an infectious organism. [25] 
In patients with post operative hypotony, eye rubbing should be avoided 
due to the risk of fluid ingress via external scleral opening if the tunnel is 
not sutured. [26] 
 
DIAGNOSIS 
CLINICAL FEATURES: [20] 
The following signs and symptoms mimicking uveitis are present: 
 Decreased visual acuity 
 Floaters 
 Lid edema 
 Conjunctival injection with or without chemosis 
 Corneal edema 
 
 
 Corneal infiltrate/endothelial plaque 
 Hypopyon 
 Anterior chamber reaction 
 Loss of iris pattern with boggy iris 
 Posterior synechiae 
 Relative Afferent pupillary defect 
 Inflammatory plaque in capsular bag [1] 
 Vitreous inflammation 
 Retinitis/Retinal periphlebitis 
 Loss of red reflex 
 The EVS determined that some clinical features of the initial 
presentation were predictive of the microbiological results. [7]They 
include: 
 Symptom onset within 2 days  of surgery 
 Light perception visual acuity 
 Afferent pupillary defect 
 Wound abnormalities 
 Corneal infiltrate 
 Hypopyon > 1.5 mm 
 Loss of red reflex 
 
 
These findings were commonly associated with gram negative 
bacteria and gram positive bacteria other than coagulase negative spp. 
Bacterial endophthalmitis present within first week of surgery with 
classical  
 Pain 
 redness, 
 discharge, 
 blepharospasm  and 
  worsening of symptoms. 
 
Fungal endophthalmitis is typically associated with a latent period of 
several months with 
 mild ocular pain, 
 granulomatous Keratic precipitates, 
 yellow white lesions with fluffy border in posterior pole, 
 whitish exudates along the vessels, 
 fluffy snow ball like clumps in vitreous 
 
Prompt recognition of endophthalmitis is of utmost importance and 
suspicion of infection is most critical in the diagnosis of endophthalmitis. 
 
 
 
 
Differential diagnosis 
1. Occult retention of lens cortex or nucleus 
2. Hypopyon uveitis (Behcet’s or rifabutin) 
3. Blebitis 
4. Keratitis 
5. Toxic anterior segment syndrome (TASS)  
6. Phaco anaphylaxis 
7. Vitreous Wick Syndrome 
In TASS, typical clinical picture is diffuse limbus to limbus corneal 
edema marked anterior chamber inflammation detected on the first 
postoperative day. [20]  
Symptoms include variable pain and impaired vision, fixed or 
almost fixed dilated pupil, severe elevation of intraocular pressure, and 
iris thinning or atrophy.   
The implicated cause is the use of improperly cleaned or processed 
instruments, which allows denatured residual viscoelastic or enzyme 
detergents to enter the patient's eye during cataract surgery. [19] 
It is difficult to distinguish TASS from endophthalmitis in early 
postoperative period when it is caused by virulent organisms. Careful 
follow up is needed in these patients to watch for endophthalmitis. 
 
 
 
Clinical diagnosis 
A thorough evaluation of the patient is very important 
 Best corrected visual acuity 
 Measurement of RAPD 
 External examination 
 Detailed slit lamp examination 
 Indirect Ophthalmoscopy (for vitritis, retinitis, choroiditis, 
periphlebitis, status of red reflex, retinal detachment etc.) 
 Grading aqueous flare, cells, vitritis, media clarity 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EVALUATION OF A CASE OF ENDOPHTHALMITIS 
 
Prompt and accurate diagnosis of cases of suspected infectious 
endophthalmitis is essential to establish appropriate and timely treatment, 
which is central to any opportunity for a successful outcome. 
Suspected cases must be carefully and frequently observed and timely 
action taken to obtain ocular fluids for microbiological studies. 
a)Aqueous cells 
  +1 5-10 cells 
  +2 11-20 cells 
  +3 21-50 cells 
  +4 >50 cells 
b)Aqueous flare 
    0- complete absence 
  +1-Faint(just detectable) 
  +2-Moderate(Iris and lens details clear) 
  +3-Marked(Iris and lens details hazy) 
  +4- Intense(severe fibrinous exudates in AC) 
 
 
 
 
 
c)Vitreous haze 
    0- No infiltration 
  +1- scattered fine coarse infiltration, fundus clearly seen 
  +2-Few scattered fine coarse infiltration, fundus clearly seen 
  +3- scattered fine coarse infiltration, but fundus seen 
  +4-dense infiltration, no fundus view 
 
d)Media clarity (assessed by Indirect ophthalmoscopy)[4] 
Grade1-Media clarity 6/12 view of fundus 
Grade 2-Media clarity<6/12 view of fundus , second order retinal 
vessels can be visualised 
Grade 3-Can see some retinal vessels 
Grade 4-vessels not seen, red reflex present 
Grade 5-red reflex absent 
 
 
 
 
 
 
 
 
 
Important points in differentiating bacterial and fungal 
endophthalmitis 
BACTERIAL FUNGAL 
Early symptoms 
Increasing discomfort, some pain 
Early symptoms 
Increasing redness, some pain, 
visual impairment 
Late symptoms 
Severe pain, visual impairment, 
photophobia 
Late symptoms 
Pain subsides, redness, 
photophobia and reduced vision 
Early signs 
Increasing hyperaemia, mild 
corneal edema, conjunctival 
injection and chemosis, aqueous 
flare and cells, vitritis, venous 
sheathing 
Early signs 
Conjunctival injection, mild 
corneal edema, marked aqueous 
reaction, hazy vitreous face 
Late signs 
Marked lid swelling, conjunctival 
injection and chemosis, corneal 
edema, hypopyon, exudation in 
anterior and posterior chambers, 
loss of red reflex, vitreous 
suppuration 
Late signs 
Transient small hypopyon, 
localised green white areas in 
anterior vitreous near papillary 
border, fluffy cotton balls, 
fibrinous purulent strands and 
vitreous abcesses and exudates 
 
 
 
Microbiological diagnosis 
When to culture 
 Whenever a patient presents with signs and symptoms of infectious 
endophthalmitis, it is mandatory to obtain intraocular tissue samples for 
culture. 
Post operative uveitis -When to Culture [20] 
1. Excessive intraocular inflammation associated with an alteration in 
globe integrity (e.g., suture removal) 
2. Hypopyon (in the absence of known predisposing factor, e.g., 
intravitreal thrombin use; corneal ulcer in phakic eye without vitritis) 
3. White plaque and chronic intraocular inflammation not responding to 
corticosteroids 
4. Beaded opacities in the anterior chamber or vitreous not responding to 
corticosteroid therapy 
5. conjunctival filtering bleb opacification if there is associated ac and 
vitreous reaction 
6. Severe Intraocular inflammation unresponsive to intensive topical 
corticosteroids 
 
 
 
 
 
Specimens to be cultured: 
A biopsy specimen of: 
 Aqueous fluid 
 Vitreous fluid  
Should be collected from patients presenting with acute post 
operative endophthalmitis. 
They are sent for Culture and gram stain. 
Diagnostic techniques 
Endophthalmitis can be diagnosed confirmatively by 
demonstrating organisms in the eye. In eyes with suspected 
endophthalmitits, samples of aqueous and vitreous should be obtained 
prior to instituiting therapy. Even in eyes with predominant anterior 
chamber inflammation, vitreous cultures are more sensitive than aqueous. 
Diagnostic Procedures 
1. Aqueous tap 
2. vitreous tap/biopsy 
 
Method of aqueous tap 
 Aqueous tap should be done with strict asepsis under topical 
anaesthesia. A tuberculin syringe with 5/8 inch,30G needle or 27G needle 
is used to make a stab entry at temporal limbus into AC and 0.1-0.2ml of 
 
 
aqueous is aspirated .It is important to keep bevel of needle away from 
corneal endothelium during injection. 
It can also be done using a keratotomy to the level of descemet’s 
membrane with a needle knife for controlled entry into AC, But if the eye 
is phakic with narrow anterior chamber, it may damage the lens. It is 
avoided in AC  containing vitreous to prevent vitreous wick formation. 
 
Collection of vitreous specimen 
Several techniques have been described to collect vitreous samples (via 
limbus or pars plana) 
a) Needle aspiration(vitreous tap) 
b) Automated instruments(vitreous biopsy) 
 
a) Needle aspiration 
Via limbus-In aphakic eyes, the anterior hyaloids face can be 
entered with a 26 G needle after entry via limbus and a pocket of 
liquefied vitreous can be aspirated. This is blind and potentially 
dangerous technique, since aspiration of vitreous gel can lead to retinal 
breaks in the periphery. In addition, the vitreous strands form a track to 
the site of needle entry. 
 
 
 
In pseudophakic eyes, Foster described a limbal approach to enter 
vitreous cavity through the iridectomy or through the pupil outside the 
IOL margin. He performed a small keratotomy through which the needle 
is manouvered. But vitreous aspiration itself is a blind procedure. 
Pars plana approach- In phakic and preferably in pseudophakic 
eyes,a pars plana approach is better since it obviates the problem of 
vitreous incarceration as in limbal approach. Retrobulbar anaesthesia is 
must for this approach to collect vitreous specimen , specimen can be 
collected by either a needle or vitreous cutter. Needle aspiration involves 
the use of 26/27G needle and syringe aspiration. For reasons explained 
above use of needle is a satisfactory approach. 
 
b)Use of automated instruments 
 If only vitreous tap is contemplated without full fledged 
vitrectomy, the surgical procedure is done under retrobulbar or general 
anaesthesia.Sterile preparation of the area is done for any other surgical 
procedure. Conjunctival opening for a single sclerotomy about 3.5 mm 
from limbus is done, sclerotomy is made with 20G MVR blade. The 
suction port of the vitreous cutter is connected to a syringe via a  silicone 
tubing for manual aspiration. The cutter is introduced into midvitreous 
cavity and cutting is activated while the assistant aspirates slowly. After 
0.5ml of the vitreous is collected, suction and cutting are stopped and the 
 
 
cutter is withdrawn. The sclerotomy is closed and the volume is made up 
by injecting balanced salt solution into the vitreous cavity, using 30G 
needle. In view of hypotony that takes place during the procedure, some 
author advocate placement of infusion cannula through a separate port. 
Advantages 
 Least traumatic way to collect vitreous specimen 
 The simultaneous cutting and aspiration enables the removal of 
vitreous without any traction on the vitreous base, thus reducing 
the risk of iatrogenic retinal breaks. 
Smear preparation 
 Smears of intraocular fluid are prepared by spreading one drop 
over its surface by tilting the slide using a sterile needle. They are air 
dried and fixed for 3 minutes in 95% methyl alcohol prior to staining. A 
grams and giemsa should be performed within minutes. One should be 
cautious about initiating treatment based on preliminary stains, as it 
should be confirmed by culture. Additional slides should be fixed and 
kept available for-PAS, calcoflour white and gomori’s methanamine. 
Culture media 
One or 2 drops of fluid placed directly on blood, chocolate and 
sabourad’s agar plates and spread by tilting plates (without allowing fluid 
to touch the edge). For anaerobic medias like Robertson’s cooked meat 
 
 
media or sodium thioglycollate broth 1-2 drops of the specimen is 
inoculated at the bottom with a long, sterile(spinal)needle. 
Specimen obtained by vitrectomy should be diluted with variable amount 
of BSS from infusion. A membrane filter system or centrifugation is used 
for culture. The intraocular specimens are directly inoculated on to the 
culture media at the place of aspiration. 
Laboratory is instructed to keep all the negative cultures for atleast 
1 to 2 weeks prior to discarding. 
Culture Positivity 
A culture is defined positive when the same organism grow in 
more than one media at inoculation site. Growth in only one liquid 
medium or scanty growth in one solid medium is of “uncertain 
significance”. All cultures are incubated for atleast 7 days. [28] 
Sl no. Media Atmosphere Temperature(in 
degree celcius) 
1 Blood agar Aerobic& 
anerobic 
35-37 
2 Chocolate agar CO2 35-37 
3 Brain heart infusion 
broth 
Aerobic 35-37 
4 Thioglycollate broth Aerobic 35-37 
5 Sabouraud’s 
dextrose agar 
Aerobic 25-27 
35-37 
 
 
 
Radiology and Ultrasonographic studies 
Useful tool especially when there is no fundus view due to 
inflammation, complicated cataract or vitritis. 
It gives a clue of: 
 Vitreous involvement(seen as fine vitreous opacities involving the 
anterior and posterior vitreous) 
 Thickening of retino-choroido-sclera complex.(suggestive of 
inflammation involving the retina and choroid) 
 Detect any retinal detachments 
 To detect any retinochoroidal abcess 
 Involvement of sclera (As it gives a clue of how fast it may involve 
the orbital fat leading to panophthalmitis) 
MANAGEMENT 
Management of exogenous endophthalmitis is by: 
 Medical 
 Surgical 
 
 
 
 
 
 
 
Medical management 
Intravitreal antibiotics: 
 In 1944 Von Saumann and colleagues demonstrated that injection 
of penicillin  successfully treated S.aureus endophthalmitis in a rabbit. 
The study represented a major turning point to the therapeutic approach 
to endophthalmitis. 
 It is the route of choice and principal modality of treatment in 
infectious endophthalmitis. It is beneficial in all cases with initial vision 
of hand movements or better, used along with topical antibiotics and 
steroids. Improvement is heralded by slow regression and retraction of 
exudates.  
Utmost care should be taken in preparing and diluting antibiotics to 
avoid iatrogenic damage to the retina. 
Role of intravitreal antibiotics: 
 According to Gordon SM et al (1997) intravitreal injections 
bypasses blood retinal barrier and rapidly achieve therapeutic level at the 
site of injection. 
In past 20years, several authors have studied the modality of antibiotics to 
be used .An ideal drug should have: 
 Good anti bacterial activity against both gram negative and gram 
positive organisms. 
 
 
 No toxicity to retina and other ocular structures 
 Has an appropriate half life to be therapeutic. 
Presently no single antibiotic covers all the organisms that induce 
endophthalmitis, a combination of atleast two drugs is required. 
Rationale for combining two antibiotics include: (Daniel B Roth et al 
1997) 
1. They should provide broader spectrum of coverage of most of the 
organisms. 
2. Minimising toxicity of drug “A” by using a lower dose of drug “A” 
and adding drug “B” without any  toxicity. 
3. Minimising the emergence of resistant strains. 
4. Providing synergy between 2 drugs. 
5. Has an appropriate half life to be therapeutic. 
 Daniel B.Roth et al (1997)has suggested that certain drug 
combinations act synergistically with each other. Antimicrobial 
synergism is defined as a greater inhibitory or bactericidal activity from 
two or more drugs than would be expected merely from the sum of 
activities of the individual drugs. Synergism is an organism specific 
phenomenon that exists for one species or strain of species but not 
another. The intra-ocular environment may change the pharmacokinetics 
 
 
and within a given species of organism, one strain may exhibit synergism 
while another may not. 
Examples 
 Beta-lactam and aminoglycosides often exhibit synergy together 
against gram-negative organisms and decrease the potential for resistant 
strains. 
1. Vancomycin and Amikacin (aminoglycosides) have been shown to act 
ssynergistically against various organisms, especially the enterococcus 
species. 
2. Vancomycin+ Beta lactam have effect on Gram positive and 
sometimes Gram negative organisms. 
The main stay of treatment for gram positive bacteria is 
vancomycin in the dose of 1mg/0.1 ml solution. It has been shown in the 
EVS study that 100% of gram positive bacteria respond to vancomycin 
including methicillin resistant Staph.aureus. [27] 
For gram negative organisms, Aminoglycosides like Amikacin 
were used previously in a dosage of 0.4mg/0.1ml.This was the antibiotic 
used in EVS study. Due to its toxic effects, Amikacin has been replaced 
by Ceftazidime recently. Ceftazidime is a third generation cephalosporin 
covering majority of gram negative organisms. It has been reported that 
100% gram negative isolates were sensitive to Ceftazidime when 
 
 
compared with 97% for Amikacin. [28] The dosage of Ceftazidime is 
2.25mg/0.1ml. 
In vitro, Vancomycin when combined with Ceftazidime in the same 
syringe is known to produce a precipitate and so they should be injected 
from separate syringes.  
 Clearance of drug occurs either anteriorly through the aqueous 
outflow channels (Vancomycin, Aminoglycoside) or posteriorly 
across the retina (Cefazolin and Clindamycin) 
 3rd generation Cephalosporins (Ceftazidime) in eliminated in both the 
routes. 
 Anterior cleaning drugs have longer half-lives. 
 Antibiotic clearance is significantly increased in aphakic and 
vitrectomised eyes. 
 Intraocular inflammation may increase or decrease clearance 
depending on the primary route of drug elimination. 
 Data suggest that in humans most intravitreal antibiotics are 
maintained at potentially effective concentrations for approximately 
48hrs after initial injection.[29] 
 No toxicity was demonstrated with a single injection. But repeated 
injections at interval of 48 hrs were associated with increasing degree 
of retinal toxicity. 
 
 
Drugs Used in the Endophthalmitis Vitrectomy Study for Treatment 
of Acute Postoperative Endophthalmitis 
 
B) Topical 
Fortified drops are better to achieve higher concentrations. Topical 
antifungals like Natamycin 5% suspension in suspected fungal infection. 
Cycloplegics and steroids are also used. 
 
 
Route of 
administration 
Drug Dose 
Intravitreal Vancomycin 
Amikacin 
1.0 mg in 0.1 mL 
0.4 mg in 0.1 mL 
Subconjunctival Vancomycin 
Ceftazidime 
Dexamethasone 
25.0 mg in 0.5 mL 
100 .0 mg in 0.5 mL  
6.0 mg 
Topical Vancomycin  
Amikacin 
50.0 mg/ml  hrly 
20.0 mg/mL hrly 
Systemic Ceftazidime  
Amikacin  
 
Prednisone 
2.0 g iv QID 
7.5 mg/kg initially 
then 6mg/kg hrly  
30 mg/day(for 5–10 
days) 
 
 
Commonly used fortified antibiotics are: 
 Gentamycin 1.5% 
 Amikacin 1.5% 
 Cefazolin 5% 
c) Sub conjunctival and periocular injections 
These approaches are aimed at achieving higher concentration of 
drugs in the eye. [30] Subconjunctival antibiotics administration is 
associated with higher therapeutic concentrations within the aqueous 
humor of eye. [31] 
Subconjunctival Vancomycin (25 mg) and Ceftazidime (100 mg) 
[32] can be used as a regime in pending culture and sensitivity report. 
d) Systemic 
The EVS shown that there was no difference in visual outcome 
when intra venous systemic antibiotics like Amikacin and Ceftazidime 
are used as adjuncts to intravitreal antibiotics in cases of acute and 
subacute endophthalmitis. [7] 
 
 
 
 
 
 
 
 
 
Surgical management: 
Vitrectomy 
 
Surgical management of choice is vitrectomy which removes the 
sequestered infectious pockets in the eye. It also removes inflammatory 
debris, toxins and clears the media and reduces the risk of late 
complications with cellular proliferation into the vitreous matrix. 
It is indicated in: 
 No improvement or actual worsening of condition clinically after 
24hrs of conservative treatment. 
 Moderate to advanced stages of infection(absence of fundal glow on 
initial presentation) 
Advantages of Vitrectomy 
1. Reduces infection load, clears potentially toxic bacterial products 
like debris relevant in fungal infections 
2. Allow better penetration of antibiotics as they are delivered 
directly to infection site 
3. Fast clearing of visual axis 
4. Removal of vitreous scaffold for the formation of scar tissue as 
vitreous membranes may result in RD 
5. Permits intra vitreal drug therapy and ease the circulation of drugs. 
 
 
6. Enhances intra-ocular fluid circulation and thereby natural 
immune defense mechanisms. 
7. It makes available abundant material for culture. 
 
Disadvantages of vitrectomy 
1. Increased risk of antibiotic induced retinal toxicity 
2. Risk of retinal detachment 
3. Technical difficulties in inflamed eyes 
4. Surgical and anaesthetical complications 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
COMPLICATIONS 
Major adverse events in EVS study included: 
 Retinal detachment -8.3% 
 Pthisis bulbi-3% 
 Significant rise in IOP-1% 
Macular abnormalities were the most common cause of visual loss in 
the EVS. These included :   
 macular edema 
 macular ischemia 
  pigmentary degeneration of macula 
  epiretinal membrane 
These macular abnormalities were more common in patients with 
worse presenting  acuity, in 17% of patients with hand motions or better 
acuity and up to 40% of patients presenting with PL + acuity. In eyes 
with PL+ that did not receive vitrectomy ,excess visual loss was due to 
anterior segment media opacification (15%) and phthisis or enucleation 
(23%).  
Retinal detachment and antibiotic toxicity are significant as they 
may go in for further poor vision in spite of successful treatment of the 
infections. Macular infarction can occur after the use of intraocular 
aminoglycosides manifesting as whitening in the macula.[33,34] 
 
 
AIM 
 
            To identify the factors which predict the prognosis in patients with 
acute post operative endophthalmitis following cataract surgery. 
 
OBJECTIVES: 
1. To study the different modes of presentation of endophthalmitis 
2. To determine the demographic factors, preoperative, intra operative 
and post operative risk factors which significantly affect the visual 
outcome of acute post operative endophthalmitis patients. 
3. To analyse the visual outcome in relation to time of 
presentation,clinical features and treatment modality. 
4. To study the variety of organisms causing endophhalmitis 
5. To study the various treatment modalities. 
6. To study the complications of exogenous post cataract surgery 
endophthalmitis. 
  
 
 
MATERIALS AND METHODS 
STUDY DESIGN:  Prospective observational study  
STUDY PLACE:  Department of Cataract and IOL Services, 
Aravind Eye Hospital and Post graduate Institute of 
Opthalmology, Madurai. 
STUDY PERIOD: 1 year (January 2013-December 2013)  
STUDY POPULATION: All patients who underwent cataract extraction   
without or with IOL implantation in the same sitting, who developed 
acute post operative endophthalmitis. 
SAMLE SIZE: 60 individuals 
SAMPLING: Simple random sampling  
 
INCLUSION CRITERIA:  
All patients presenting to IOL department with clinical signs of 
endophthalmitis within 6 weeks after cataract surgery 
 
EXCLUSION CRITERIA: 
1. Endophthalmitis secondary to other surgical procedures 
2. Patients presenting with traumatic or endogenous endophthalmitis. 
3. Patients presenting with Toxic Anterior Segment Syndrome  
4. Patients who lack follow up. 
 
 
5. Patients presenting with endophthalmitis more than 6 weeks 
following cataract surgery. 
6. Patients who underwent secondary IOL implantation following 
cataract extraction a few months back. 
 
HOW THE STUDY WAS CONDUCTED:  
Acute postoperative endophthalmitis was diagnosed based on clinical 
features including: 
 Pain 
 Redness  
 Decreased visual acuity 
 Diffuse conjunctival congestion 
 Chemosis 
 Scleral infiltrate 
 Corneal infiltrate, keratic precipitates 
 Severe inflammation of anterior segment (with one of the 
following criteria: 
 Cells 
 Flare 
 Hypopyon height 
 Fibrillary membrane 
 
 
 Exudates in AC 
 Posterior segment inflammation (all patients had vitreous 
infiltration which was diagnosed biomicroscopically or by 
ophthalmic ultrasonography) 
A baseline evaluation form was completed during the initial 
examination of each patient which includes: 
 Demographic details 
 Systemic history 
 Ocular history 
 Details of cataract surgery(retrospectively collected from 
previous records of the patient and from the surgeon  
including: ) 
 Type of cataract surgery 
 Type of IOL implantation 
 Duration of surgery 
 Intra operative complications including posterior 
capsular rupture,zonular dialysis and vitreous 
loss) 
 Details of intervention done 
 Post op day 1 complications 
 Data of initial ocular examination 
 
 
 Post op day of presentation and visual acuity at presentation 
 
Performance of PPV or core vitrectomy was left to the discretion of 
the treating retina surgeon. 
On admission, an immediate aqueous tap or vitreous tap or 
scraping of corneal ulcer was done followed by intravitreal injection of 
vancomycin hydrochloride(1mg per 0.1ml), Ceftazidime (2mg per 0.1ml) 
and Dexamethasone (0.4mg per0.1ml). Intravitreal steroid is avoided in 
suspected fungal infection. In patients who are allergic to Penicillin, 
Amikacin(0.4mg in 0.1ml) was considered in place of Ceftazidime. 
Undiluted vitreous samples were also collected during PPV. 
After biopsy, material was sent for: 
 Gram staining 
 KOH staining 
 Culture 
 Blood agar 
 Sabourad’s agar 
 Thioglycollate broth 
 Brain heart infusion broth 
No transport media was used. Inoculation was done immediately. 
 
 
All patients were started on broad spectrum antibiotics and 
antifungals were added for patients with clinically fungal infection. 
When causative organism was identified, specific antibiotic was 
given during repeat intravitreal or during vitrectomy. 
The patients were followed up during the study period for first 
month and third month, at every followup visit, visual acuity, detailed slit 
lamp examination, indirect ophthalmoscopy was done and recorded and 
treatment modified accordingly. 
Statistical methods 
 The data were expressed as Mean (SD) or Frequency (percentage) 
as needed.  Wilcoxon signed rank sum test was used to assess the 
difference between pre and post data.  Logistic regression analysis was 
used to find out the risk factor associated with visual outcome.  P-value 
less than 0.05 considered as statistically significant.  All statistical 
analysis was done by statistical software STATA 11.1 (Texas, USA). 
 
  
RESULTS AND OBSERVATIONS
This prospective study was conducted at Aravind
Postgraduate Institute of Ophthalmology Madurai, during 
to December 2013. 60 consecutive patients were included in the study 
and they were followed up for a period of three months.
1.
Age 
Age category
≤60 
>60 
Total 
 
The age distribution of patients ranged from 40 years to 80 years.
0%
20%
40%
60%
80%
100%
 
 
 Eye Hospital and 
January
 
  Demographic pattern 
 n % 
27 45.0 
33 55.0 
60 100.0 
45%
55%
<=60 >60
AGE
 2013 
 
 
Sex 
Male 
Female 
Total 
 
Out of the patients, 46.7% were 
 
 
 
 
46.7%
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Sex 
n % 
28 46.7 
32 53.3 
60 100.0 
Male and 53.3% were Female
 
53.3%
Female
Sex
 
 
 
 
 
Eye 
Eye n % 
Right eye 31 51.7 
Left eye 29 48.3 
Total 60 100.0 
 
In the study, right eye was affected in 31 patients (51.7%), left eye was 
affected in 29 eyes (48.3%) 
 
 
 
 
 
 
 
 
 
 
 
 
Time from surgery to endophthalmitis presentation
Time interval
<7 days 
8 – 30 days
 31 – 42 days  
Total 
 
In this study, 17 patients presented within one week of surgery
 
28.3%
0%
20%
40%
60%
80%
100%
<7 days
Day of presentation from surgery date 
 
 
 n % 
17 29.3 
 36 62.1 
 7 11.7 
60 100.0 
 (29.3%)
60%
11.7%
8 – 30 days 31 – 42 days 
 
 
 
 
Ocular infection at pre-op 
Ocular 
infection 
n % 
Yes 1 1.7 
No 59 98.3 
Total 60 100.0 
 
Duct at pre-op 
Duct Study eye Other eye 
Free 59 98.3 
Partially free - - 
Not free 1 1.7 
Total 60 100.0 
 
Of the 60 patients, only 1 patient had an ocular infection and 1 had a 
nasolacrimal duct obstruction. 
 
 
 
 
 
Type of cataract
IMC
MC 
PSCC
Total
  
90% of the patients had IMC, 8.3% had 
had PSCC. 
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Type of cataract 
 n % 
 54 90.0 
5 8.3 
 1 1.7 
 60 100 
Mature cataract and 1.7% 
8.3%
1.7%
MC PSCC
Type of cataract
 
 
 
Other ocular pathology 
Ocular pathology n % 
Exotropia 1 11.1 
Corneal opacity 1 11.1 
High Myopia 1 11.1 
POAG 1 11.1 
PXF 2 22.2 
PXF, Phacodonesis 1 11.1 
Pterygium 1 11.1 
concretions 1 11.1 
 
Pre existing pathologies like PXF, myopia were present in a total 
of 9 out of 60 patients. 
 
 
 
 
 
 
 
 
Systemic illness
Diabetes 
Hypertension
Cardiac 
Asthmatic 
Others 
Systemic illness
Yes 
No 
Total 
 
Systemic illness-diabetes was present in 10 patients (16.7%)
 
 
 
 
33.3%
0%
20%
40%
60%
80%
100%
 
Systemic illness 
 n % 
10 16.7 
 11 18.3 
3 5.0 
1 1.7 
3 5.0 
 n % 
20 33.3 
40 66.7 
60 100.0 
66.7%
Yes No
Systemic illness
 
 
Type of surgery
PHACO 
MSICS 
ECCE 
Total 
 
Out of 60 patients,
patients, MSICS in 43(71.7%) and ECCE (2%) patients.
 
 
 
 
 
 
25%
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40%
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80%
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PHACO
 
Type of surgery 
 n % 
15 25.0 
43 71.7 
2 3.3 
60 100.0 
 Phacoemulsification was done in 15(25%) 
 
71.7%
3.3%
SICS ECCE
Type of surgery
 
Type of IOL
PMMA 
Hydrophobic Acrylic
Hydrophilic Acrylic
Total 
 
PMMA IOLs were used in 44(73.3%) 
Acrylic IOL in 5 patients(8.4%) and Hydrophilic Acrylic
11(18.3%) 
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Type of IOL 
 
 n % 
44 73.3 
 5 8.4 
 11 18.3 
60 100.0 
of patients, Hydrophobic 
 
 
Hydrophilic Acrylic
5
11
IOL in 
Surgery duration
<=15 minutes
16 – 30 minutes
31 – 60 minutes
>60 minutes 
Total 
 
Surgery duration < 15 minutes was found in 44 pa
out of 60 patients and duration > 60 minutes was found in 1 patient(1.7%)
 
 
 
15%
10%
 
Surgery duration 
 n % 
 44 73.3 
 9 15.0 
 6 10.0 
1 1.7 
60 100.0 
tients
73.3%
1.7%
Surgery duration
<=15 minutes
16 – 30 minutes
31 – 60 minutes
>60 minutes
 (73.3%) 
 
 
 
 
Intra-op complication 
 
Intra-op complication n % 
Yes 
        PCR with VD 
        PCR without VD 
        ZD 
       Premature entry 
 
6 
4 
2 
1 
 
 
10.0 
6.7 
3.4 
1.7 
No 47 78.3 
Total 60 100.0 
 
21.7% of patients had intra operative complications out of which 
10% had PCR with vitreous disturbance. 
 
Intra-op complication 
 
 
% 
Yes 21.7% 
No 78.3% 
  
 
 
 
 
 
 
  
Intervention 
Automated Vitrectomy
CTR 
Suturing at tunnel
Manual Vitrectomy
 
Intra op intervention like
6.7%) of patients and tunnel suturing done in 
 
 
21.7%
0%
20%
40%
60%
80%
100%
Intra
 
Intervention done 
n % 
 4 6.7 
2 3.3 
 5 8.3 
 1 1.7 
 automated  vitrectomy was done 
5(8.3% )of cases. 
78.3%
Yes No
-op complication
in 4( 
 
Complication at day 1
Yes 
No 
Total 
 
 Out of 60 patients, 10 (16.7%) had complications at post operative 
day 1, including corneal striate ker
IOL.  
 
 
 
 
 
 
 
16.7%
0%
20%
40%
60%
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Complication at day 1
Complication at day1
Corneal SK 
Decentered IOL 
FM 
 
Complication at day1 
 
 n % 
10 16.7 
50 83.3 
60 100.0 
atitis,  decentred IOL and FM over 
83.3%
Yes No
 n % 
4 6.7 
4 6.7 
1 1.7 
 
 
 
On the day of presentation: 
Clinical presentation n % 
Scleral infiltrate 
      Yes 
       No 
 
3 
56 
 
5.1 
94.9 
Cornea 
      Clear 
      Epithelial edema 
      SK 
      KPs 
      DM folds 
      Infiltrate 
      Corneal melt 
      Pigments 
      Ulcer 
 
17 
17 
5 
4 
20 
5 
2 
2 
1 
 
28.3 
28.3 
8.3 
6.7 
33.3 
8.3 
3.3 
3.3 
1.7 
AC 
      No view 
      1+ cells 
      2+ cells 
      3+ cells   
      4+ cells 
      Quiet 
      Shallow 
 
2 
2 
8 
23 
23 
1 
5 
 
3.3 
3.3 
13.3 
38.3 
38.3 
1.7 
8.3 
Hypopyon 
      Nil 
     Trace 
      0.5 mm 
      1 mm 
 
15 
1 
7 
22 
 
26.3 
1.8 
12.3 
38.6 
 
 
      1.5 mm 
       2 mm 
     >2 mm 
      No view 
6 
4 
1 
1 
10.5 
7.0 
1.8 
1.8 
FM over IOL 
      Yes 
      No 
 
42 
16 
 
72.4 
27.6 
Exudates in AC 
      Yes 
      No 
 
11 
47 
 
19.0 
81.0 
Red reflex 
      Present 
      Absent 
 
9 
49 
 
15.5 
84.5 
Vitreous cells 
      Yes 
      No 
 
17 
41 
 
29.3 
70.7 
Vitreous exudates 
      Yes 
      No 
 
3 
55 
 
5.2 
94.8 
USG B-Scan 
RCS thickness 
      Mean(SD) 
      Min – Max  
 
1.83(0.31) 
1.41 – 3.72 
 
 Co-existing RD 
      Yes 
      No 
 
 
 
2 
57 
 
3.4 
96.6 
Others 
    PVD 
    Vitreous membrane
    Vitreous schisis
    Choroidal effusion
    Dropped lens matter
   CDs seen temporally
 
 
 
42 patients (72.4%) had FM over IOL
patients (19%) had exudates in AC and 49 patients had absence of red 
reflex (84.5%). 
72.4%
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9 
16 
7 
2 
1 
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15.0 
26.7 
11.7 
6.1 
3.0 
3.0 
 at presentation and 11 
19%
15.5%
81%
84.5%
Exudates Red reflex
Yes No
 
  
Out of 60, only 2 patients (3.4%) had associated retinal 
detachment, vitreous membranes over had in 16 patients (26.7%) and 
Choroidal detachment in 1 patient (3%).
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96.6%
No
Co-existing RD
 
 
 
Treatment 
Treatment n % 
Medical 
      Steroid /Antibiotic 
      Antifungal 
      Fortified amikacin 
Cefazolin & Aminogen 
 
55 
3 
1 
1 
 
91.7 
5 
1.7 
1.7 
AC tap with I/C Antibiotics 
      Yes 
      No 
 
9 
51 
 
15.0 
85.0 
Vitreous tap with I/V Antibiotics 
      Yes 
      No 
 
37 
23 
 
61.7 
38.3 
AC and Vitreous tap with I/V 
Antibiotics 
      Yes 
      No 
 
 
9 
51 
 
 
15.0 
85.0 
Core vitrectomy with I/V 
Antibiotics 
      Yes 
      No 
 
 
9 
51 
 
 
15.0 
85.0 
Core vitrectomy with I/V 
Antibiotics 
      Primary procedure 
      Secondary procedure 
 
 
2 
7 
 
 
22.2 
77.8 
  
Core vitrectomy  
initial procedure in 16(26.7%) of the patients and as a secondary 
procedure after AC or vitreous tap in 44(73.3%) of patients.
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was done in 9 (15%) of patients. It was done as 
 
 
38.3%
No
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73.3%
Secondary procedure
 
 
Clinical picture
Normal 
Residual inflammation
Total 
 
Out of the 60 patients
whereas 19 (31.7%)  showed Normal clinical picture. 
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1month 
Clinical picture 
 
 n % 
19 31.7 
 41 68.3 
60 100.0 
,   41 (68.3%) had Residual inflammation
 
Residual inflammation
41
 
 
 
 
Complication 
 
Complication n % 
Yes 10 16.7 
No 50 83.3 
Total 60 100.0 
 
 
Complication at 1month n % 
Epithelial defect over graft 1 10 
Fresh RD and CD 2 20 
Fundus hazy 1 10 
Inferior RD 1 10 
Posterior synchiae 1 10 
Retracting FM 1 10 
Thin PCO 1 10 
Tight sutures over graft 1 10 
Total corneal abscess going for 
pthisis 
1 10 
 
 
 
 
 
 
Intervention 
Intervention n % 
AC tap with AC wash and I/C 
Vancomycin 
1 12.5 
DCR 1 12.5 
Evisceration 1 12.5 
PPV with SOI 2 25.0 
Scleral buckling 1 12.5 
Topical antibiotics 1 12.5 
suture removal 1 12.5 
 
Out of the 10 patients(16.7%) who had complication at 1 month 
follow up, three patients had Retinal detachment (30%) , 1 had a total 
corneal  perforation with iris prolapse (prepthisis) for which evisceration 
was done. 
 
 
 
 
 
 
 
 
 
Clinical improvement
Yes 
No 
Total 
 
 49 patients (81.7%) showed clinical improvement at 3 months 
follow up  and 11 patients (18.3%) 
clinical picture.  
 
 
 
81.7%
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3month 
Clinical improvement 
 n % 
49 81.7 
11 18.3 
60 100.0 
 did not show any improvement in 
18.3%
No
 
 
 
Complication 
Complication n % 
Yes 18 30.0 
No 42 70.0 
Total 60 100.0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Complication at  3months n % 
Dense membrane over IOL 1 5.6 
Disc temporal pallor 1 5.6 
ERM 1 5.6 
Failed TPK graft 1 5.6 
Failed patch graft 1 5.6 
Iris bombe with occlusio pupillae 1 5.6 
Corneal edema 1 5.6 
NVD and Retinitis 2 11.1 
Optic capture with fibrous PCO 2 11.1 
Pthisis 4 22.2 
Recurrent endopthalmitis 2 11.1 
Corneal scar, PS, Secondary 
glaucoma 
1 5.6 
 
 
Microbiology 
Culture results 
Culture results n % 
Positive 19 31.7 
Negative 41 68.3 
Total 60 100.0 
 
 
Gram results 
Gram results n % 
Gram positive cocci 13 68.4 
Gram positive bacilli 2 10.5 
Gram negative cocci - - 
Gram negative bacilli 3 15.8 
Fungi 1 5.3 
Total 19 100.0 
 
 
 Out of 60 patients, only 19 patients (31.7%) were culture positive 
and 41 patients (68.3%) were culture negative. Of the culture positive, 13 
(68.4%) had Gram positive cocci grown in culture which is similar to 
EVS study. 2 patients (10.5%) showed Gram positive bacilli and 3 
patients (15.8%) showed 
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Gram negative bacilli, Fungi in 1 patient (5.3%). 
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Organisms 
       Organisms Freq Percent 
Aspergillus flavus 1 5.26 
 Bacillus spp. 1 5.26 
Citrobacter koseri  1 5.26 
Delftia acidovorans 1 5.26 
Nocardia 1 5.26 
Non hemolytic staphylococcus sp. 1 5.26 
Pseudomonas 1 5.26 
Staphylococcus sp. 1 5.26 
 Staphylococcus aureus 1 5.26 
Staphylococcus capitis 1 5.26 
Staphylococcus epidermidis 5 26.32 
 Staphylococcus hemolyticus 3 15.79 
 Streptococcus pneumoniae 1 5.26 
Total 19 100.00 
 
Among the 19 culture positive cases(31.7%), Staph.epidermidis 
was found in 5 cases(26.32%) followed by Staph hemolyticus in 3 
cases(15.79%). 
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Best corrected visual acuity –a comparative analysis 
BCVA 
Median 
(Snellen’s 
equivalent) 
Mean(SD) Min – Max P-value 
 Pre-op 0.78(6/36) 0.90(0.68) 0.18 – 2.6 <0.001 
Day1 0.18(6/9) 0.35(0.44) 0 – 2.6 
Presentation 2.3(FCF) 1.91(0.94) 0.18 – 3.2 - 
1month 0.48(6/18) 0.80(0.89) 0 – 3.2 <0.001 
3month 0.3(6/12) 0.73(0.90) 0 – 3.2 <0.001 
 
 
BCVA At presentation 1month 3month 
6/6 – 6/18  10(16.7) 31(51.7) 37(61.7) 
<6/18 – 6/60  3(5.0) 14(23.3) 12(20.0) 
<6/60 – 3/60  4(6.7) 2(3.3) 1(1.7) 
<3/60 – 1/60  7(11.7) 5(8.3) 2(3.3) 
1/2/60 2(3.3) 1(1.7) 2(3.3) 
HM 21(35.0) 2(3.3) 1(1.7) 
FCF 6(10.0) 2(3.3) - 
PL 6(10.0) 1(1.7) 2(3.3) 
NOPL 1(1.7) 2(3.3) 3(5.0) 
Total 60(100.0) 60(100.0) 60(100.0) 
 
We found that 6 patients had PL + at presentation and No PL in 
one patient at presentation, but 3 patients were PL negative at 3 months. 
 
 
BCVA-analysis before and after presentation
 
 
 
 Median BCVA at presentation is FCF and at 3 months is 6/12.  37 
patients (61.7%) had visual acuity 
perception of light and 3 patients (5%) with no PL.
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≥6/18 and 2 patients (3.3%) with 
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 We did a comparative analysis of BCVA at presentation,  at 1 
month and at 3 months. We found that visual improvement is seen even 
in patients with poor vision at presentation if appropriate intervention is 
given early. 
We classified the patients as having vision >=6/18 at 3 months 
follow up as good outcome and <=6/18 as poor outcome and analysed the 
factors which may contribute to good 
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Factors associated with good visual outcome (>=6/18) 
Variable 
Visual outcome at 
3month 
Unadjusted Adjusted 
>=6/18 <6/18 OR(95% CI) P-value OR(95% CI) P-value 
Age 
>60 
<=60 
 
15(45.5) 
22(81.5) 
 
18(54.5) 
5(18.5) 
 
1.00 
5.28(1.61 – 
17.33) 
 
- 
0.006 
 
1.00 
6.89(1.29 –
36.78) 
 
- 
0.024 
Time of 
presentation 
>1 week 
      Within a     
week 
 
29(67.4) 
8(47.1) 
 
14(32.6) 
9(52.9) 
 
1.00 
0.43(0.14 – 
1.35) 
 
- 
0.148 
 
- 
- 
 
- 
- 
VA at 
presentation 
<1/60 
>=1/60 
 
21(58.3) 
16(66.7) 
 
15(41.7) 
8(33.3) 
 
1.00 
1.43(0.49 – 
4.19) 
 
- 
0.516 
 
- 
- 
 
- 
- 
Systemic illness 
      Yes 
      No 
 
10(50.0) 
27(67.5) 
 
10(50.0) 
13(32.5) 
 
1.00 
2.08(0.69 – 
6.23) 
 
- 
0.192 
 
- 
- 
 
- 
- 
Surgery type 
      Others 
      SICS 
 
10(58.8) 
27(62.8) 
 
7(41.2) 
16(37.2) 
 
1.00 
1.18(0.38 – 
3.72) 
 
- 
0.776 
 
- 
- 
 
- 
- 
Surgery duration 
>15 minutes 
<=15 minutes 
 
9(56.2) 
28(63.6) 
 
7(43.8) 
16(36.4) 
 
1.00 
1.36(0.42 – 
4.36) 
 
- 
0.603 
 
- 
- 
 
- 
- 
Hypopyon 
<=1 
>1 
 
23(76.7) 
8(72.7) 
 
7(23.3) 
3(27.3) 
 
1.00 
0.81(0.17 – 
3.91) 
 
- 
0.795 
 
- 
- 
 
- 
- 
FM over IOL 
   Yes 
   No 
 
30(71.4) 
7(43.8) 
 
12(28.6) 
9(56.2) 
 
1.00 
0.31(0.09 – 
1.03) 
 
- 
0.055 
 
- 
- 
 
- 
- 
Exudates in AC 
      Yes 
      No 
 
4(36.4) 
33(70.2) 
 
7(63.6) 
14(29.8) 
 
1.00 
4.13(1.04 – 
16.37) 
 
- 
0.044 
 
1.00 
11.87(1.67 – 
84.07) 
 
- 
0.013 
 
 
Red reflex 
      Present 
      Absent 
 
6(66.7) 
31(63.3) 
 
3(33.3) 
18(36.7) 
 
1.00 
0.86(0.19 – 
3.87) 
 
 
- 
0.845 
 
- 
- 
 
- 
- 
 
 
 
RCS thickness 
>=1.83 
<1.83 
 
15(53.6) 
22(71.0) 
 
13(46.4) 
9(29.0) 
 
1.00 
2.12(0.72 – 
6.20) 
 
- 
0.171 
 
- 
- 
 
- 
- 
Vitreous tab 
with I/V 
Antibiotics 
      No 
      Yes 
 
 
10(43.5) 
27(73.0) 
 
 
13(56.5) 
10(27.0) 
 
 
1.00 
3.51(1.17 – 
10.53) 
 
 
- 
0.025 
 
 
- 
- 
 
 
- 
- 
Culture results 
      Positive  
      Negative 
 
9(47.4) 
28(66.7) 
 
9(52.6) 
14(33.3) 
 
1.00 
2.39(0.78 – 
7.30) 
 
- 
0.125 
 
- 
- 
 
- 
- 
Intra-op 
complication 
      Yes 
      No 
 
5(38.5) 
32(68.1) 
 
8(61.5) 
15(31.9) 
 
1.00 
3.41(0.95 – 
12.21) 
 
- 
0.059 
 
1.00 
7.27(1.36 – 
38.94) 
 
- 
0.020 
Post-op 
complication 
      Yes 
      No 
 
13(41.9) 
24(82.8) 
 
18(58.1) 
5(17.2) 
 
1.00 
6.65(2.00 – 
22.04) 
 
- 
0.002 
 
1.00 
4.56(1.05 – 
19.75) 
 
- 
0.042 
1month 
complication 
      Yes 
      No 
 
4(40.0) 
33(66.0) 
 
6(60.0) 
17(34.0) 
 
1.00 
2.91(0.72 – 
11.74) 
 
- 
0.133 
  
3month 
complication 
      Yes 
      No 
 
4(20.0) 
33(82.5) 
 
16(80.0) 
7(17.5) 
 
1.00 
18.86(4.81 – 
73.9) 
 
- 
<0.001 
  
  
 22 patients with age <60 
whereas 18 patients (54.5%) 
<6/18. Age is on important predictive factor as we found that patient’s 
age <60 years had 5 times chance of getting good visual outcome.
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21 patients (58.3%) with presenting acuity <1/60 had good visual 
outcome ≥6/18 and 15 patients (61.7%) who presented with <1/60 had 
poor visual outcome. Most patients (66.7%) with presenting acuity > 1/60 
had good outcome. 
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28 patients (63.6%) with cataract 
good visual outcome and 7 patients with cataract surgery duration > 15 
minutes had poor visual outcome.
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  Out of 60 patients,
visual outcome and 3 patients (27.3%) with 
visual outcome. 
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 23 (76.7%) with hypopyon <1 mm had good 
hypopyon >1mm had poor 
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30 patients (71.4%) with FM over IOL had good visual outcome 
and 12 patients (28.6%) with FM over IOL had poor outcome
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Out of 11 patients with exudates in AC,only 4 (36.4%) had good 
visual outcome and 7(63.6%) had poor visual outcome.We found that 
patients with no exudates in anterior chamber had 4 times higher chance 
of getting good visual outcome than those with exudates in AC.This is a 
significant factor affecting the visual prognosis in our stud
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Mean RCS thickness was found to be 1.83 and if RCS thickness 
was <1.83, it was associated with good visual outcome.
RCS thickness <1.83 (71%) who had good visual outcome and 13 
patients (46.4%) with RCS thickness >1.83 had 
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Out of 60 patients,
antibiotics (61.7%). Out of these 37, 27 patients
outcome and remaining 10 (27%) had poor visual outcome. We found 
that patients treated with vitreous tap with I/V antibiotics have 3 times 
higher chance of getting good visual acuity 
importance of vitreous tap with i/v antibiotics 
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 37 were treated with vitreous tap with I/V 
 (73%) had good visual 
≥ 6/18. This emphasizes the 
in endophthalmitis patients.
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We had 18 patients
patients(47.4%) had good visual outcome and 99 patients (87.6%) had 
poor visual outcome. Among the culture negative, 28(66.7%) had good 
visual outcome and 14(33.3%) had poor visual outcome.
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5 patients(38.5%) with intra op complications had good visual 
outcome and 8 patients (61.5%) with intra operative complications had 
poor visual outcome. Those patients without intra operative 
complications have 3 times more chance of getting good visual outcome 
than those without intra op complications.This has been found as a 
significant factor for good visual prognosis in our study.
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 6 patients (60%) with complications at 1 month follow up had poor 
visual outcome and 31 patients
visual outcome. 
 
33 patients (82.5%) without any complication at 3 months had 
good visual outcome. 
40.0%
0%
20%
40%
60%
80%
100%
>=6/18
1 month complication
20.0%
0%
20%
40%
60%
80%
100%
>=6/18
 
 (66%) without complications had good 
60.0%
66.0%
34.0%
<6/18
Yes No
80.0%82.5%
17.5%
<6/18
3 month Complication
Yes No
 
 
 
 
Variable 
Visual outcome at 
3month 
Adjusted 
>=6/18 <6/18 OR(95% CI) P-value 
Age 
>60 
<=60 
 
15(45.5) 
22(81.5) 
 
18(54.5) 
5(18.5) 
 
1.00 
6.89(1.29 – 36.78) 
 
- 
0.024 
Exudates in AC 
      Yes 
      No 
 
4(36.4) 
33(70.2) 
 
7(63.6) 
14(29.8) 
 
1.00 
11.87(1.67 – 84.07) 
 
- 
0.013 
Intra-op 
complication 
      Yes 
      No 
 
 
5(38.5) 
32(68.1) 
 
 
8(61.5) 
15(31.9) 
 
 
1.00 
7.27(1.36 – 38.94) 
 
 
- 
0.020 
Complication at 
1 month 
      Yes 
      No 
 
 
4(40.0) 
33(66.0) 
 
 
6(60.0) 
 17(34.0) 
 
 
1.00 
8.53(1.32 – 54.92) 
 
 
- 
0.024 
 
From our study, it is evident that age<60yrs, absence of exudates in 
AC, with no intra operative complications or at 1 month were associated 
with good visual outcome (>6/18) 
 
 
 
 
 
 
DISCUSSION 
Endophthalmitis after cataract surgery is less common but a very 
serious complication. To manage this disease well, it is necessary to 
know the clinical presentation and infecting organism and treatment 
modality. 
Several studies were published regarding the epidemiology, 
incidence and clinical presentation of acute endophthalmitis in Western 
literature and a few recent studies in Indian subcontinent. A study of 
incidence and outcome in our centre has already been published. [3] 
Incidence was found to be 0.053% 
Those studies which consider prognostic factors of endophthalmitis 
were mostly retrospective .Very few studies were prospective and the 
factors may differ in different population groups. One such study is 
needed in South Indian population to standardize collection of clinical 
data at the time of presentation and microbiology techniques. 
Our study was mainly conducted to assess the clinical presentation, 
microbiological picture and visual outcome in acute exogenous 
endophthalmitis and the factors associated significantly with good visual 
outcome. These factors may help to assess the severity of the disease 
indicating a necessity for early aggressive intervention. 
 
 
 
Study By No. of 
Patients 
Type of study and 
Centres 
Study 
Period 
Types of 
Surgery 
1)EVS group[7] 420 Randomized control 
trial, 
24 centres 
4 years Phacoemulsification, 
Corneal/sclera 
incisions,secondary 
IOL 
2) Aur.lie 
Combey et al[17] 
99 Prospective cohort,4 
centres 
1.5 years Corneal phaco and 
ECCE 
3)Taraprasad 
Das et al[36] 
128 Prospective, single 
centre 
6 years ICCE, ECCE, GFS, 
Vitrectomy, Yag cap 
4) Wendy V. 
Hatch et al[35] 
617 Retrospective, multi 
centred 
4 years Phaco, ECCE 
5) Jerry A. 
Menikoff et 
al[24] 
54 Case control 
study,single centre 
2 years Phaco, ECCE 
6)Prajna Lalitha 
et al[3] 
19 Retrospective, single 
centre 
2 years Phaco, MSCS, ECCE 
7)Our study 60 Prospective,single 
centre 
1 year Phaco, MSCS, ECCE 
 
 
 
 
 
 
 
Age distribution 
In the present study, patients age ranged from 45-80 years. Mean 
age in our study was 61 years.  
In EVS study, mean age was 75 years. [7]  
Aur.lie Combey et al has reported a mean age of 73 years. [17] 
Lalitha P et al has reported a mean age of 67.5 years.[3] 
We found that age < 60 years as a significant factor associated with 
good visual outcome of > 6/18. 
Only in EVS study, it has been reported that older age is risk factor 
for decreased visual acuity. [7]They also found that patients of any age had 
1.5 risk of having final visual outcome than the patients  who are 10 years 
younger than them.  
Exudates in AC 
Exudates in Anterior chamber was found in 11 (19%) of patients 
and absent in 47 (81%) of patients. 
We found in our study that absence of  Exudates in AC was 
significantly associated with good visual outcome(>6/18). 
Exudates in AC was found in 5 culture positive patients, out of 
which 2 showed positivity for Staphylococcus epidermidis,1 for 
staphylococcus hemolyticus,1 for Delftia acidovorans and 1 showed 
 
 
positivity for Aspergillus flavus  and remaining 6 patients were culture 
negative. 
Exudates in AC refer to severe inflammatory reaction and fungal 
endophthalmitis are known to have fluffy exudates in AC. 
Haripriya et al has reported the presence of cotton ball exudates in 
AC and corneal endothelium in 24 cases of  Nocardia endophthalmitis. 
[40] 
Intra operative complications 
In our study, we had 13(21.7%) patients with intra operative 
complications during cataract surgery and 47 patients (78.3%) without 
intra operative complications. Of these 13 patients, 6 patients (10%) had 
PCR with vitreous disturbance for which automated and manual 
vitrectomy was done, 2 (3.4%) had Zonular Dialysis for which CTR was 
placed, 4 patients(6.7%) had PCR without vitreous disturbance was 
done,1 (1.7%) had Premature entry for which suture was placed at tunnel. 
  
Out of the 13 patients with intra operative complications, only 5 
(38.5%) had good visual outcome >6/18. Remaining 8 (61.5%) had poor 
outcome. 
 
 
This result is consistent with other studies. In EVS study, an open 
posterior capsule was found to be an independent risk factor for poor 
visual outcome [7] 
Study by Aurelie et al has shown that absence of complications 
during cataract surgery is an independent factor for good visual acuity. [17] 
Lalitha P  et al has reported that Intra operative PCR was a significant 
risk factor for endophthalmitis independent of age, type of surgery, and 
gender. [3].The hypothesis as stated in literatures is that bacterial 
elimination is less efficient from vitreous cavity than from anterior 
chamber.PCR  may lead to prolonged duration of surgery with more 
instrumentation which are additional factors contributing to infection. 
          Menikoff et al [24] has reported 13.7 times higher risk of developing 
endophthalmitis in patients with PCR. 
 
Complications at 1 month 
In our study, we found that patients who still had complications at 
1 month follow up even after aggressive treatment for endophthalmitis 
tend to have a poor outcome. Those patients without any complications at 
1 month follow up had a good outcome at 3 months. 
 
 
 
Out of 60, 10(16.7%) had complications at 1 month and remaining 
50(83.3%) had no complications at 1 month. Out of these 10 patients, 
6(60%) had poor visual outcome<6/18 at 3 months and 4 (40%) had good 
outcome >6/18. 
There were 3 patients (30%) with Retinal Detachment, 1 
patient(10%) with epithelial defect over the corneal graft,1(10%) had 
Retracting FM,1 (10%) had active inflammation with Posterior  synechiae 
and FM over IOL,1 patient (10%) had tight sutures over the graft and 
1(10%) had Total corneal abcess going in for pthisis of that eye and 
1(10%) patient had thin PCO. 
2 patients (25%) with RD were treated with Pars plana Vitrectomy 
with Silicone Oil implantation and 1(12.5%) with Scleral Buckling, 1 
patient (12.5%) with posterior synechiae was treated with AC tap with 
AC wash and Intracameral Vancomycin. Suture removal was done in 
1(12.5%) patient with a tight suture. Evisceration was done in 1(12.5%) 
patient with total corneal abcess becoming pre-pthisical. 
At 3 months, 4 patients went for pthisis (22.2%), 2 (11.1%) had 
NVD and retinitis, 2 (11.1%) had failed graft and 2 (11.1%) had 
recurrence of endophthalmitis. 
In EVS study, it was reported that at final vist, 5% had RD,1% had 
high IOP,3% had pthisis, 1% had evisceration. [7]  
 
 
In a study by Aurelie et al, 7% of patients had RD, 3% had CD, 8% 
had ERM,8% went for pthisis, 6% had macular edema. [17] 
 
Visual outcome 
In our study, visual outcome of patients at 3 months follow up 
showed that 37(61.7%) had >=6/18 vision,12(20.0%) had <6/18-
6/60,1(1.7%) had <6/60-3/60,2(3.3%) had <3/60-1/60,2(3.3%) had 
1/2/60,1(1.7%) had HM,2(3.3%) had PL and 3(5%) had No PL. 
In EVS study, At 3 months, 41% of patients achieved 20/40(>=6/12) or 
betterVisual acuity and 69% had 20/100 or better acuity. [7]  At final visit 
5% had no PL similar to our study. 
In Aurelie et al study, 31% of patients had V/A worse than 
20/100(<6/36) 45% had 20/40 or better acuity. [19] 
Another study from our centre by  Lalitha P et al reported that 
visual outcome of endophthalmitis was generally poor with only 29.4% 
had visual acuity >20/40. [3] 
 
Microbiology 
In our study, only 18 cases (31.7%) had culture positivity and 
remaining 42(68.3%) were culture negative. Of the culture positive case, 
9(47.4%) patients had visual outcome>6/18 and 9 (52.6%) had poor 
 
 
visual outcome<6/18. Among the culture negative cases 28(66.7%) 
patients had visual outcome and 14(33.3%) had poor visual outcome. 
Among the culture positive, Staph epidermidis was the commonest 
followed by Staph hemolyticus.  
This is in concordance with EVS study showing that coagulase 
negative staphylococci as the commonest organisms. Also in EVS study 
69% patients were culture positive and 12.5% had equivocal results. [7]A 
study from North India by  Gupta A  et al shows culture positivity in 38% 
patients and equivocal growth in 18% patients. They reported 
Pseudomonas and fungi were the common organisms. 
We had 1 patient with Nocardia infection who  presented with deep 
corneal infiltrate for which patch graft was done but there was graft 
failure at 3 months. 1 patient with Pseudomonas  infection presented with 
total corneal abcess and went for pthisis. 1 patient was found to have 
Aspergillus flavus  infection who presented with corneal infiltrated for 
which intrastromal Voriconazole twice and TPK was done but the patient 
went for graft failure at 3 months. Another patient with Bacillus infection 
had corneal perforation with uveal prolapse who underwent evisceration 
at 1 month. 
  
 
 
Aurelie et al has reported that culture negative cases seem to have 
good visual outcome. [17] It has been postulated that culture negative cases 
have low level of inoculums that cannot be easily detected by 
conventional culture method. Our study also found culture negative 
patients have a better visual outcome than culture positive individuals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIMITATIONS OF OUR STUDY 
 
The following were the limitations of my study: 
 
 The factors were analysed only for patients who presented to us 
< 6 weeks. 
 Patients were followed up for only 3 months 
 Population included in this study is homogenous. 
 
Hence the results could not be generalised in all settings of 
endophthalmitis Further long term multicentre trials are needed for that. 
  
 
 
CONCLUSION 
        In our study of acute postoperative endophthalmitis, we found that         
age < 60 years, absence of exudates in AC, absence of intra operative 
complications and absence of post operative complications at 1 month 
follow up were associated with good visual outcome >6/18. 
 
Since the recent trend is shifting from SICS to corneal phaco 
emulsification, the risk factors for good and poor prognosis need to be 
updated from time to time. Baseline factors defining the prognosis of the 
patients with endophthalmitis may help in aiding the clinicians in 
segregating the patients who may need immediate and aggressive 
intervention and those patients who need a ‘wait and watch’ before 
intervention. 
 
Although recent techniques of microbiology like RT-PCR are 
emerging, we still can find culture and PCR negative endophthalmitis 
which may attribute to low infectivity or sterile endophthalmitis and 
should be treated according to clinical presentation. 
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FACTORS PREDICTING VISUAL OUTCOME IN 
POST OPERATIVE ENDOPHHALMITIS 
FOLLOWING CATARACT SURGERY 
STUDY PROFORMA 
DEMOGRAPHIC INFORMATION 
Study Id:     Name:    
M.R.No.:       Age:       
Sex:        Date of presentation: 
Place:      Post op day: 
PRE OPERATIVE DETAILS: 
Eye :  □ Re-1    □Le-2                                                                                                                            
UCVA: 
BCVA: 
Previous Ocular Infection: □Yes-1 □No-2 
    If yes- □Blepharitis-2a  
□Conjunctivitis-2b  
□Pustule-2c 
□hordeolum internum/externum-2d 
      □Others (Specify): 2e 
Duct:  □Free -1 □Partially Free  With : Clear Fluid/Pus-2 
□Not Free-3 
 
 
 
 
Type Of Cataract: 1) IMC 2) MC 3)PCIOL4) others-mention 
Systemic Illness: □DM-1 □HT-2 □Cardiac-3 
 □Asthmatic-4 
   Others (Specify):-5  
SURGERY DETAILS: 
Date of surgery: 
Type Of Surgery: □Phaco-1 □SICS-2 □ECCE-3 
Lens Implantation done: □Yes-1 □No-2 
If Yes,Specify: □PMMA-1 □Acrylic-2 □Aurofoldable-3 □Others-
4 
Duration Of Surgery(In Mins): 
Intra Op Complications: □Yes-1  □No-2 
If Yes, Specify: 
Intervention Done: 
 
 
 
 
 
 
 
 
POSTOP VISITS: 
 Post op 
day 1 
On the day of 
presentation 
1 month 3months 
VA     
CLINICAL 
PICTURE: 
Iris/vitreous 
incarceration at the 
wound 
p-1,a-2 
 
    
Scleral infiltrate- 
p-1,a-2  
    
Corneal infiltrate- 
 p-1,a-2 
    
Hypopyon(mm)     
Pupillary reaction 
(normal-1 
Sluggish-2 
RAPD-3) 
    
FM over IOL 
p-1,a-2 
    
Exudates inAC 
p-1,a-2 
    
Red reflex 
p-1,a-2 
 
    
 
 
Vitreous cells 
p-1,a-2 
    
Vitreous exudates 
p-1,a-2 
    
 
USG B scan: 
a)vitreous opacities 
p-1,a-2 
b)coexisting RD/CD 
p-1,a-2 
c)RCS thickness 
 
    
TREATMENT 
MODALITY 
a.medical 
b. AC tap with 
intracameral 
antibiotics 
c.corneal scraping y-
1,n-2 
d.vitreous tap with 
intravitreal 
antibiotics 
y-1,n-2 
e.core vitrectomy 
with intravitreal 
antibiotics y-1,n-2 
f. Core vitrectomy 
    
 
 
0-nil 
1- as a primary 
procedure 
2- as a secondary 
procedure 
g.others 
Microbiological 
identification: 
Culture negative-1 
Culture positive-2 
If positive: 
organism(specify) 
    
 
 
 
  
 
 
ABBREVIATIONS 
GFS  - Glaucoma filtering surgery 
ECCE - Extracapsular capsular cataract Extraction 
ICCE  - Intracapsular Cataract Extraction 
HM  - Hand movements 
PL  - Perception of light 
AC  - Anterior chamber 
PCR  - Posterior Capsular rupture 
PCO  - Posterior Capsular Opacification 
ZD  - Zonular Dialysis 
CTR  - Capsular Tension Ring 
Spp  - Species 
I/V  - Intra Vitreal 
I/C  - Intra cameral 
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1 Nagarathinam 3507382 1 64 1 Ramnad 30 1 6/24 6/9 2 1 1 2 1 1,2,5
Stroke,Hy
percholest
erolemia
1 1 Aurofoldable 5 2 6/9 2 5\60 2 2
KPs,DM 
folds 2+ cells,2+flare NIL 2 1 2 2 2 2
2 Panjavarnam 3493921 1 65 2 Virudhunagar 12 1 3/60 3/60 2 1 1 1 1 2 1 1 Aurofoldable 20 2 6/9 2 PL Present 2 2
epithelial 
edema 2+ cells,3+flare Nil 2 1 2 2 1 2
3 Ruby 3528157 1 45 2 madurai 55 1 6/60 6/18 2 1 1 1 1 1 1 Aurofoldable 5 2 6/9 2 FCF 2 2 clear 4+cells,1+flare 2 2 2 1 2 1 2
4 Sivagami 3529363 1 65 2 madurai 20 1 6/60 6/12 2 1 1 1 1 1 1 Aurofoldable 15 2 6/12 1
1 haptic in 
sulcus 6/9 2 2 clear 4+cells,1+flare 1 2 1 2 2 1 2
6 Ayyavu 3549645 1 65 1 Namakkal 4 1 HM HM 2 1 2 1 3 2 1 Acrysof 15 2 6/12 2 HM 2 2 clear 2+cells,1+flare 1 2 1 2 2 1 1
7 Arumugam 3044776 1 63 1 Madurai 3 2 6/60 6/12 2 1 1 1 3 3 1 1 Acrysof 5 2 6/6 2 CFCF 2 2 DM folds 4+cells,1+flare 2 2 2 2 2 1 2
10 Indrani 3579987 1 84 2 Dindigul 18 1 6/60 6/12 2 1 1 1 1 1 1 1 Aurofoldable 15 2 6/9 2 HM 2 2
epithelial 
edema 4+cells,1+flare 0.5 1 1 2 2 1 2
11 Kameswari 3590242 1 45 2 Andhra Pradesh 19 2 6/60 6/36 2 1 1 1 1 1 1 PMMA 35 1
PCR/vit 
dis/tempo
ral tunnel
Automa
ted vit 6/9 2 PL Present 2 2
epithelial 
edema 4+cells,1+flare nil 3 2 1 2 1 2
12 Sainaba Beevi 3588185 1 67 2 Salem 12 1 6/36 6/18 2 1 1 1 3 1 1 Acrysof 5 2 6/18 2 4/60 2 2 Corneal infiltrate 1+cells nil 2 2 1 2 1 2
15 Seeni Avul 2789769 1 66 1 madurai 2 1 6/24 6/9 2 1 1 1 3 1 1 aurofoldable 15 2 6/9 1
K-epi 
edema,AC-
3+cells
6/18 2 2 epithelial edema 3+cells,1+flare 1 2 1 2 2 2 2
16 Bharathy 3618781 1 72 2 madurai 6 2 HM HM 2 1 2 1 3 1,3 2 1 Acrysof 10 1 Small pupil MST 6/9 2 6/12p 2 2
DM 
folds,SK1+ 2+cells,1+flare nil 2 2 2 1 1 2
17 Mayandi 3625455 1 50 1 madurai 6 1 1/60 6/12 2 1 1 1 1 1 1 Aurofoldable 10 2 6/6 2 6/36 2 2
epithelial 
edema 4+cells,1+flare 0.5 1 2 2 1 1 2
18 Chidambaram 3544073 1 68 1 Pudukkottai 12 1 6/9 6/9 2 1 1 1 1 1 1 1 Aurofoldable 10 1
Small 
pupil
Iris 
hooks 
used
6/6 2 HM 2 2 DM folds Shallow,1+cells 0.5 2 1 2 2 2 2
19 Amaravathy 1266632 1 55 2 Dindigul 31 1 6/36 6/24 2 1 1 Pterygium 1 1 1 1
Aurofold
able 20 2 6/9 2 HM 2 2
epithelial 
edema 3+cells,2+flare 1 2 1 1 2 2 2
20 Mohanraj 8703028 1 52 1 Trichy 7 1 1/60 1/60 2 1 1 1 1 1 1 Aurofoldable 10 2 6/9 2 HM 2 2
DM 
folds,epithel
ial edema
3+cells,1+flare 1 2 1 2 2 1 1
22 Santhosam 3641632 1 65 2 madurai 20 2 6/36 6/12 1 ACCO 1 1 POAG 1 1 1 1 1
Aurofold
able 15 2
Tempor
al 
tunnel
6/9 2 6/9 2 2
Deep 
stromal 
infiltrate
4+cells,2+flare 1 2 1 2 2 2 2
23 Krishnaveni 3713524 1 65 2 Chennai 10 2 6/18 6/9 2 1 1 1 1 1,2 1 1 Acrysof 10 2 6/18 1
K-SK 
2+,,AC-
2+cells
6/12 2 2 DM folds,SK1+ 2+cells,1+flare nil 1 2 2 2 1 2
24 Pankajam 1294264 2 65 2 madurai 45 2 6/60 6/18 2 1 1 1 1 2 1 PMMA 15 2 6/6 1 K-superior SK1+ 6/9 2 2
KPs,DM 
folds 3+cells,1+flare 1 2 1 2 2 2 2
25 Raju 1310662 1 62 1 kerala 31 2 5/60 6/60 2 1 1 1 3 2 1 PMMA 20 1 PCR
1 suture 
at 
tunnel
6/24 2 HM 2 2 DM folds 4+cells,1+flare nil 2 1 2 2 2 2
26 Thangarasu 1312212 1 65 1 madurai 12 2 6/9 6/9 2 1 1 Exotropia 1 1 2 1 PMMA 10 2 6/9 2 CFCF 2 2 DM folds 4+cells,1+flare 0.5 2 1 2 2 2 2
27 Eswaran 1320576 2 43 1 Virudhunagar 15 2 6/24 6/9 2 1 1 concretions 1 1 2 1 PMMA 10 2 6/6 2 HM 2 2
DM 
folds,SK1+ 4+cells,3+flare 0.5 1 1 2 1 2 2
28 Subramanian 1323177 2 67 1 madurai 16 1 6/60 6/12 2 1 1 1 1 4 2 1 PMMA 10 2 6/6 2 HM 2 2 epithelial edema 4+cells,2+flare 1 2 1 2 1 2 2
30 Perumalakkal 1325081 2 45 2 Virudhunagar 13 1 4/60 6/24 2 1 1 1 1 3 1 PMMA 60 2
5 
sutures 
at 
wound 
6/12 2 6/12 2 2 clear 4+cells.3+flare 1 2 1 1 2 2 2
31 Arumugavalli 1325143 2 45 2 Ramnad 11 1 6/18 6/18 2 1 1 1 1 2 1 PMMA 15 2 6/9 2 HM 2 2 epithelial edema 4+cells,2+flare 2 1 1 2 2 2 2
32 Vempu 1328795 2 57 1 Perambalur 26 1 1/2/60 1/2/60 2 1 1 1 1 2 2 1 PMMA 10 2 6/12 2 HM 2 2 clear 3+cells,2+flare 1 1 1 2 2 2 2
33 Peeramma 1327239 2 72 2 Andhra Pradesh 38 1 6/24 6/18 2 1 1 1 2 2 1 PMMA 10 2 6/24 2 PL Present 2 1 ulcer
3+cells,shallow 
,NVI,Iris 
prolapse
nil 4 2 1 2 2 2
34 Vasantha 1336305 2 55 2 Dindigul 5 2 HM HM 2 1 2 1 1 2 1 PMMA 10 2 6/18 2 HM 2 2
DM 
folds,pigme
nts on 
endothelium
2+cells,3+flare 1 2 1 2 2 2 2
35 Kasthuri rangan 1343932 2 79 2 madurai 6 2 HM HM 2 3 2 1 1 2 1 PMMA 15 2 6/18 2 PL Present 2 2 Total corneal melt no view no view no view no view no view no view no view no view
37 Bhuvaneswari 1354646 2 40 1 Virudhunagar 21 1 6/60 6/12p 2 1 3 High Myopia 1 4 2 1 PMMA 10 2 6/9 2 2/60 2 2
epithelial 
edema
Shallow,4+cell
s nil 2 1 2 2 2 2
39 Karanthi 1068596 2 60 2 Melur 7 2 2/60 6/60 2 1 1
PXF,Ph
acodon
esis
1 1 2 1 PMMA 20 1 Nasal ZD CTR 6/12 2 1/60 2 2
epithelial 
edema,SK1
+
3+cells,1+flare nil 2 1 2 1 2 2
41 Muniyandi 3679121 2 60 1 Dindigul 27 1 5/60 6/36 2 1 1 1 1 2 1 PMMA 15 2 6/6 2 6/36 2 2 clear quiet nil 1 2 2 2 1 1
42 Karuppi 1370535 2 50 2 Sivagangai 28 2 6/60 6/36 2 1 1 1 1 2 1 PMMA 15 2 6/36 2 HM 2 2 clear 4+ cells 1.5 2 1 2 2 2 2
43 Madasamy 1381706 2 65 1 madurai 5 2 6/36 6/12 2 1 1 2 1 1 2 1 PMMA 60 1 Premature entry
2 
sutures 
at 
tunnel,S
6/18 2 HM 2 2 SK 2+ 3+cells,1+flare 1 2 1 2 1 2 2
44 Saroja 1384889 2 65 2 madurai 2 1 2/60 2/60 2 1 1 1 1 2,3 2 1 PMMA 15 2 6/60 1
K-SK 
1+,Epithelial 
edema,AC-
2+cells
PL Present 2 2 Infiltrate
shallow 
AC,3+cells,2+f
lare
nil 3 1 2 2 2 2
45 Karuppayeeammal 1318803 2 52 2 madurai 2 2 6/12 6/9 2 1 1 1 3 2 1 PMMA 5 1 PCR
Automa
ted vit 6/18 1
K-temporal 
SK+, HM 2 2
epithelial 
edema 2+cells,1+flare nil 1 2 2 1 2 2
46 Abdul majeed 1394493 2 57 1 Tanjore 27 2 6/12 6/12 2 1 1 1 1 2 1 PMMA 10 2 6/9 2 6/24 2 2 DM folds 4+cells,1+flare 1 2 1 1 2 1 2
47 Kasimkan 1293006 3 66 1 madurai 10 2 1/60 1/60 2 1 1 1 1 1,2 2 1 PMMA 10 2 6/9 2 1/60 2 2 DM folds 3+cells,2+flare 2 2 1 2 2 2 2
48 vasantha 1291257 3 77 2 madurai 7 2 6/60 6/60 2 1 1 1 3 3 1 PMMA 30 2 6/36 2 1/60 2 2
epithelial 
edema,DM 
folds
3+cells,2+flare 3 2 2 2 2 2 2
49 Mani 1303538 3 50 2 Sivagangai 10 1 6/36 6/18 2 1 1 1 1 2 1 PMMA 10 2 6/6 2 6/12 2 2 clear 3+cells,2+flare 1.5 2 1 2 2 2 2
52 Udaiyappan 1317868 3 64 1 Pudukkottai 14 1 6/60 6/12 2 1 1 1 1 2 1 PMMA 20 2 6/9p 2 HM 2 2 clear 3+cells,1+flare 0.5 2 1 2 2 2 2
53 Subburaj 1307458 3 54 1 madurai 13 2 6/60 6/12 2 1 1 1 1 2 1 PMMA 35 2 6/6 2 6/18 2 2 clear 3+cells,1+flare 1 2 1 2 2 2 2
54 Chellakannu 1321247 3 76 1 Pudukkottai 11 2 2/60 6/60 2 1 1 1 1 2,5 Nephropathy 2 1 PMMA 20 2 6/9 2 HM 2 2 clear 3+cells,1+flare 1 2 1 2 2 2 2
55 Arumbu 1321238 3 75 2 Ariyalur 2 2 6/60 6/24 2 1 1 1 3 2 1 PMMA 35 1 PCR
Manual 
vitrecto
my
1/2/60 1
FM over 
Iol,1 haptic 
in AC
HM 2 2 DM folds 4+cells,1+flare 1 2 1 2 2 2 2
57 Kaliammal 1331005 3 65 2 Dindigul 21 1 3/60 6/60 2 1 1 1 1 2 1 PMMA 5 2 6/6 2 HM 2 2 epithelial edema 3+cells,1+flare 1.5 2 1 2 2 2 2
59 Rakku 1334584 3 59 2 Sivagangai 16 1 5/60 6/24 2 1 1 1 1 5 Leprosy 2 1 PMMA 10 2 6/12 2 FCF 2 1 clear 4+cells,1+flare 1 2 2 1 2 2 2
60 Kaliamoorthy 1352233 3 71 1 Tanjore 22 1 4/60 6/60 2 1 1 PXF 1 1 2 1 PMMA 10 2 6/18 2 HM 2 1
stromal 
edema with 
DM folds
4+cells,1+flare 1 2 2 2 2 2 2
61 Ayyakannu 1356444 3 66 1 Perambalur 31 2 2/60 6/60 2 1 1 1 1 2 1 PMMA 10 2 6/12p 2 PL Present 2 2 clear shallow 1.5 2 2 1 2 2 2
62 Durairaj 3617463 3 67 1 Perambalur 5 1 3/60 6/60 2 1 1 1 1 2 2 1 PMMA 10 2 6/12 2 HM 2 2 Ring infiltrate 4+cells,2+flare
1.5mm,p
igmented 2 2 1 2 2 2
63 Pappa 3619415 3 65 2 Perambalur 7 1 3/60 6/60 2 1 1 1 1 2 1 PMMA 10 2 6/9p 2 PL negative 1 2
Infiltrate 
with melt no view no view no view no view no view no view no view no view
67 Shanthi 3665396 3 56 2 Tiruvarur 30 1 4/60 4/60 2 1 1 1 1 2 1 PMMA 7 2 6/18 2 1/2/60 2 2 clear 3+cells,1+flare 1 2 1 2 2 1 2
69 Subramanian 1366622 3 45 1 Salem 15 2 6/60 6/24 2 1 1 1 1 2 1 PMMA 10 2 6/18 2 FCF 2 2 clear 3+cells,2+flare nil 2 1 2 2 2 2
70 Amirtham 1361476 3 60 1 Tanjore 17 2 1/60 5/60 2 1 1 1 3 2 1 PMMA 5 2 6/18 2 HM 2 2 DM folds 4+cells,2+flare 1.5 2 1 2 2 2 2
71 Poongothai 1385616 3 60 2 Pudukkottai 35 2 6/60 6/36 2 1 1 Hazy cornea 1 3 1 2 1 PMMA 25 2
primary 
PCO 6/12 2 1/60 2 2 clear 3+cells,1+flare nil 2 1 2 2 2 2
72 Logambal 1377553 3 70 2 Perambalur 16 1 1/60 1/60 2 1 1 PXF 1 1 2 2 1 PMMA 15 1 Small pupil MST 6/36 2 3/60 2 2 DM folds 3+cells,1+flare nil 2 1 1 1 1 2
73 Veerammal 1383392 3 54 2 Tanjore 15 2 1/60 1/60 2 1 1 1 1 2 1 PMMA 30 1 Small pupil MST 6/9 2 1/60 2 2 clear 4+cells,2+flare 1 2 2 2 2 2 2
75 Thangavel 1398487 3 55 1 Trichy 16 1 1/60 1/60 2 1 2 1 2 2 2 1 PMMA 90 1 PCR
Automa
ted vit,1 
suture 
at 
HM 1
K-epi 
edema,AC-
3+cells
2/60 2 2 KPs,DM folds 3+cells,1+flare nil 2 1 2 2 2 2
76 Jeyalakshmi 1389574 3 80 2 Tanjore 3 2 1/60 1/60 2 1 1 1 3 2 1 PMMA 35 1 PCR Automated vit 6/24 1
K-epi 
edema,AC-
3+cells
FCF 2 2 Epithelial edema 3+cells,2+flare 1 2 1 2 2 2 2
77 Kaliyamoorthy 1400354 3 70 1 Tanjore 30 2 3/60 6/60 2 1 1 1 3 1,2 2 1 PMMA 15 2 6/6 1
nasally 
decentered 
IOL
5/60 2 2 KPs 2+cells 0.5 2 1 2 1 1 2
78 Nirmala 1401422 3 51 2 madurai 10 2 3/60 5/60 2 1 1 1 1 2 1 PMMA 10 1 6/9 2 6/9 2 2 endothelial dusting 4+cells,2+flare
Trace 
hypopyo
n
2 1 2 2 2 2
79 meiyappan 1365263 3 51 1 Pudukkottai 17 1 1/60 5/60 2 1 1 1 1 2 1 PMMA 5 2 6/12 2 1/2/60 2 2
epithelial 
edema,DM 
folds
3+cells,1+flare 1 2 1 2 2 2 2
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1 2 1.59 Vitrioschisis 1 1 2 2 2 0 6\9 Normal 4\60 2 Recurrence 1 Nil
Iris bombe 1 2 1.58 1 1 1 2 2 0
Yag 
membranol
ysis
6/12 Normal 6/9p 1 1
1 2 1.58 Vit.memb 1 2 1 2 2 0 6/6 Normal 6/6 1 1
Posterior 
synechiae 1 2 1.67 1 1 2 2 2 0 6/6 Normal 6/6p 1 1
1 2 1.56 1 2 2 2 2 0 6/9 Normal Inferior RD SB 6/9p 1 2
Non 
hemolyti
c 
staphyloc
gram 
positive 
cocci
1 2 2.14 vit memb,vit schisis 1 1 2 1 2 0 6/9 Normal 6/12 1 2
Staphylo
coccuc 
sp.
gram 
positive 
cocci
FM upto 
sideport 
and 
section
1 2 1.71 Vit memb 1 2 2 2 1 1 6/6 Normal Fresh RD and CD
PPV with 
SOI 6/60 2
NVD and 
Retinitis 1
Pupillary 
block 1 2 1.97 Vit memb 1 2 2 2 1 1 Yag PI 6/60
AC-3+cells,AVF 
cells1+ 6/36 1 1
1 2 1.67
vozole,
mycon
at hrly
2 2 2 2 0
corneal 
scraping,Int
ra stromal 
vozole inj 
1/60
Corneal graft 
infiltratw,FM 
over IOL
HM 2 Failed TPK graft 2
Aspergill
us flavus fungi
1 2 1.95 vit schisis 1 1 1 1 2 2
AC 
decompress
ion and AC 
tap
6/12 Normal 6/9 1 2 Citrobacter koseri
gram 
negative 
bacilli
1 2 1.58 Total PVD 1 2 1 2 1 2 1/60 K-DM folds,AC-1+cells
Fresh RD 
and CD
PPV with 
SOI 6/60 1
NVD and 
Retinitis 1
1 2 1.68 1 2 1 2 2 0 6/6
AC-occasional 
cells,AVF 
cells1+
6/6 1 2
Staphylo
coccus 
hemolyti
cus
gram 
positive 
cocci
Posterior 
synechiae 1 2 1.86 Vit.memb 1 2 1 2 2 0
YAG FM 
lysis 6/6 Normal
2/60 
NIG 
NIP
2
Recurrent 
endophthal
mitis
1
Posterior 
synechiae 1 2 2.03 1 1 1 2 2 0 6/12 AC-2+cells 6/9 1 2
Staphylo
coccus 
hemolyti
cus
gram 
positive 
cocci
1 2 1.58 vit memb 1 2 1 2 2 0 6/6p ERM 6/9 1 2
Staphylo
coccus 
epidermi
dis
gram 
positive 
cocci
Posterior 
synechiae 1 2 1.77 Total PVD 1 1 2 1 2 0
Corneal 
patch graft 5/60 K-patch graft 
Epithelial 
defect 
over graft
Topical 
antibiotics
6/24 
NIG 
NIP
2 Failed patch graft 1 Nocardia
gram 
positive 
bacilli
1 2 2.05 vit schisis 1 2 1 2 2 0 6/12 Ac-flare+
6/18
NIG 
NIP
1 1
Plaque 
behind 
IOL
1 2 1.86 Total PVD 1 2 1 2 2 0 6/18 AC-cells 1+ 6/12 1 1
1 2 1.45 Dropped lens matter 1 2 1 2 2 0 6/24 AC-cells 1+ 6/36 1 1
1 2 1.58 1 2 1 2 2 0 6/9 Normal 6/6 1 1
1 2 1.77 1 2 1 2 2 0 6/6 AC-occasional cells 6/6 1 1
2 2 2.05 1 2 1 2 2 0 6/6 AC-occasional cells
Retractin
g FM 6/6p 1 1
Plaque 
behind 
IOL
1 2 1.63 1 2 2 1 2 0 6/9 AC-cells 1+ 6/12 1
Optic 
capture with 
fibrous PCO
2
Staphylo
coccus 
epidermi
dis
gram 
positive 
cocci
1 2 1.7 1 2 1 2 2 0 6/12 AC-cells 1+ Thin PCO 6/12 1 1
1 2 1.77 1 2 1 2 2 0 6/6p AC-cells 1+ 6/12p 1 1
Posterior 
synechiae 1 2 1.84
CDs seen 
temporally
Fortifi
ed 
amika
cin 2% 
2 1 2 2 0 corneal scraping
PL 
prese
nt
Prepthisical eye PL-ve 2 Pthisis 2
Staphylo
coccus 
epidermi
dis
gram 
positive 
cocci
Posterior 
synechiae 1 2 1.96 1 2 1 2 1 2 6/12 AC-cells 1+ 6/12 1 2
Staphylo
coccus 
hemolyti
cus
gram 
positive 
cocci
no view 1 2 2.05 vit. Memb 1 2 1 2 2 0 corneal scraping HM
Total corneal 
abcess PL + 2 Pthisis 2
Streptoco
ccus 
pneumon
iae
gram 
positive 
cocci
Iris bombe 1 1 1.68 1 2 2 2 2 0 Yag PI HM
AC-cells 3+,flare 
2+,Inflammatory 
plaque over IOL,
Posterior  
synechiae
AC tap wih 
AC wash 
and I/C 
vancomyci
6/12 1
Iris bombe 
with 
occlusio 
pupillae
1
1 2 1.95 1 2 2 1 1 2 6/36 AC-cells 1+ 6/36 1
Disc-
temporal 
pallor
2
Staphylo
coccus 
capitis
gram 
positive 
cocci
Thick 
plaque 
over PC
1 2 1.68 Incomplete PVD 1 2 1 2 2 0 6/18 Normal 6/18 1 1
1 2 1.86 1 2 1 2 2 0 6/24 AC-2+cells 6/18 1 1
1 2 177 1 2 2 1 2 0 6/6
Few 
inflammatory 
deposits on PC
6/6 1 1
1 1 3.72 Vit.memb
Cefazo
lin e/d 
QID,A
minog
2 1 2 2 0 PL -ve
corneal 
Perforation with 
iris prolapse
Total 
corneal 
abcess 
going for 
Evisceratio
n PL-ve 2 Pthisis 2
Bacillus 
spp.
gram 
positive 
bacilli
1 2 1.67 1 2 2 2 1 1 6/24 K-DM folds,AC-1+cells 6/18 1 2
Staphylo
coccus 
epidermi
dis
gram 
positive 
cocci
Exudates 
in bag 1 2 1.95 vit memb 1 2 2 1 2 0 5/60
AC-occasional 
cells,Retracting 
FM
6/12 1 ERM 1
Inflammat
ory 
plaques 
behind 
1 2 2.01
vit 
schisis,vit. 
Memb
1 2 1 1 2 0 6/36
K-Kps on 
endothelium,Res
olving 
inflammatory 
6/18 1 1
Suture 
abcess 1 2 1.83 Total PVD
Auroz
ole e/d 
hrly
1 2 2 2 0
corneal 
scraping,An
terior 
vitrectomy 
1/60 Patch graft
Tight 
sutures 
over graft
suture 
removal
1/2/6
0 NIP 1
Dense 
membrane 
over IOL
2
Staphylo
coccus 
aureus
gram 
positive 
cocci
1 2 1.78 Total PVD 1 2 1 2 2 0
AC tap 
with AC 
tap and I/C 
vancomycin 
6/12 Normal 6/6 1 1
1 2 1.41 vit memb 1 2 1 2 2 0 6/6 normal 6/12 1 1
1 2 1.86 1 2 1 2 2 0 6/6 normal 6/6 1 1
Plaque 
over PC 1 2 1.97 1 2 1 2 2 0 6/12 AVF-cells 1+ 6/6p 1 1
Haptic in 
AC,vitreo
us at 
sideport
1 2 1.68 1 2 1 2 2 0
Ant 
vitrectomy,
IOL 
explantatio
1/2/60 AC-cells 2+,aphakia
1/2/6
0 1 1
1 2 1.77 vit memb 1 2 2 2 2 0 6/9 normal 6/9 1 1
1 2 1.86 choroidal effusion 1 2 1 2 2 0 6/60
Vit-resolving 
exudates 6/60 1 1
1 2 1.68
360 deg 
choroidal 
effusion
1 2 2 2 2 0
Patch graft 
with I/C 
vigamox
FCF Fundus-hazy PL + 2 2
Staphylo
coccus 
epidermi
dis
gram 
positive 
cocci
NVI 1 2 1.96 total PVD 1 2 2 2 1 1
IOL with 
bag 
explantatio
n with I/C 
1/60 chronic dacryocystitis DCR 6/36 1 1
1 2 2.33
vozole 
hrly,vi
gamox 
hrly
2 2 2 1 1 1/60 Resolving ring infiltrate and FM 1/60 1
corneal 
scar,PS,sec 
glaucoma
2
Delftia 
acidovor
ans
gram 
negative 
bacilli
no view
cann
ot be 
done
1 2 2 2 2 0
PL 
negati
ve
Total corneal 
melt with uveal 
prolapse
PL 
negat
ive
2 Pthisis 2 Pseudomonas
gram 
negative 
bacilli
1 2 1.67 vit memb 1 2 1 2 2 0 6/24 AC-1+cells 6/12 1 1
1 2 1.86
vit 
memb,subtot
al PVD 
attaced to 
1 2 2 2 2 0
i/v 
voriconazol
e
FCF AC-trace cells,AVF cells 6/24 1 K-edema 1
1 2 1.96 1 2 2 1 2 0 6/12 normal 6/6p 1 1
1 2 1.56 vit schisis 1 2 1 2 2 0 6/60 AC-occasional cells,vit opacities 6/36 1 1
1 2 1.95 Total PVD 1 2 1 2 2 0 6/36 Optic capture 6/36 2
Optic 
capture with 
fibrous PCO
1
Plaque 
behind 
IOL
1 2 1.77 1 2 1 2 2 0 6/12 AC-2+cells 6/9p 1 1
Iris bombe 1 2 1.86 vit memb 1 2 1 2 2 0 6/36 AC-Occasional cells 6/12 1
pigments 
over IOL 1
1 2 1.99 vit memb 1 2 2 2 2 0 6/24 retracting fm 6/24 1 pigments over IOL 1
1 2 1.86 vit schisis 1 2 1 2 2 0 6/24 Normal 6/12 1 1
1 2 1.49 1 1 1 2 1 2 6/12 Normal 6/9 1 1
Posterior 
synechiae 1 2 1.78 1 2 1 2 2 0 6/36 Normal 6/12 1 1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
